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ABSTRACT
Dopaminergic (DA) neurons in the ventral tegmental area (VTA) play a crucial role in reward
and motivational behaviors, including the development of drug addictions. VTA DA neurons
receive excitatory cholinergic inputs from the mesopontine tegmentum. Blockage of the M5
muscarinic receptor in DA neurons has been shown to attenuate drug-induced DA release and
abuse-related behaviors, but the molecular mechanism is unknown. In this study, experiments
were designed to identify the electrophysiological effects of muscarinic agonism in the
modulation of action potential kinetics and firing patterns in VTA DA neurons of mice.
Pharmacology of the muscarinic receptor-evoked current was also characterized. In the
presence of tetrodotoxin (TTX), the cholinergic receptor agonist carbachol (Carb) depolarized
membrane potential and decreased input resistance, effects that were completely inhibited
by the muscarinic receptor antagonist atropine (Atro). This carbachol-induced depolarization
caused an increase in spontaneous firing frequency without affecting firing regularity,
frequency-current relationship, HCN sag ratio, or the kinetics of action potential shape. In
addition, carbachol had no effects on spontaneous inhibitory postsynaptic currents (sIPSCs)
in VTA DA neurons. In the voltage-clamp configuration, carbachol induced a non-desensitizing
inward current and an increase in current fluctuations that were insensitive to TTX and Cs+
but sensitive to tetraethylammonium (TEA), Cd2+, and the TRPC channel blocker BTP2.
Collectively, the current evidence suggests that activation of HCN channels, inhibition of
potassium channels, and changes in inhibitory synaptic inputs do not participate in the
muscarinic slow depolarization in VTA DA neurons, but points toward activation of a nonselective cation conductance mediated by TRPC channels.
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INTRODUCTION

Cholinergic modulation of the midbrain dopamine system

The midbrain dopamine system: implications for reward and diseases
The survival of an individual or a species is dependent on motivated behaviors such as eating,
mating, learning, and avoiding dangers. In mammals, midbrain dopamine (DA) neurons
encode reward signals and modulate reinforcing behaviors. Such neural system effectively
assigns reward value and orients the organism to beneficial stimuli, but it is also vulnerable to
dysregulation in addiction disorders. Indeed, the synaptic levels of DA play a powerful and
causative role in reinforcement to food and drugs. On one hand, mice with mutations that
cause a hyperdopaminergic state showed higher food and water intake, increased sensitivity
to the rewarding effect of cocaine, and enhanced motivation for reward (Pecina et al., 2003;
Bello et al., 2011). On the other hand, mice with mutations or lesions that cause DA deficiency
were hypoactive, did not eat food or drink water, and died by 4 weeks of age (Zhou & Palmiter,
1995; Palmiter, 2008). When maintained to adulthood with daily DA supplements, these DAdeficient mice were apathetic and failed to show normal social behavior, nesting behavior,
and reward association learning (Szczypka et al., 2001; Palmiter, 2008). The hypolocomotion,
loss of motivation to feed, and the expression of learned behaviors could all be rescued by
restoration of DA signaling (Zhou & Palmiter, 1995; Szczypka et al., 2001; Robinson et al., 2005;
Palmiter, 2008). Likewise, lesions of midbrain DA neurons abolished cocaine selfadministration, whereas lesions of noradrenergic neurons had no effects (Roberts et al., 1977).
Thus, these early studies established DA as the common neural substrate that drives the
consumption of natural rewards and addictive drugs as well as permits the expression of
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reward learning.

Midbrain DA neurons comprise two major cell populations with different projection targets:
the nigrostriatal pathway that projects from the substantia nigra pars compacta (SNc) to the
dorsal striatum and the mesolimbic pathway that projects from the ventral tegmental area
(VTA) to the nucleus accumbens (NAc) in the ventral striatum (Mogenson et al., 1980;
Swanson, 1982). As a part of the motivation circuitry, VTA DA neurons also project to the
prefrontal cortex via the mesocortical pathway and to limbic structures such as the amygdala
and the hippocampus (Swanson, 1982). Traditionally, the nigrostriatal pathway is associated
with voluntary motor control, action selection, and habitual behaviors (Vanderschuren et al.,
2005; Kravitz et al., 2010; Howard et al., 2017), while the mesocorticolimbic pathways are
believed to be the hotspots for reward and reinforcement learning (Willuhn et al., 2010;
Pascoli et al., 2015). Functional segregation among DA pathways was explored by behavioral
experiments using dopamine receptor antagonists, which attenuated reward response at
doses that did not compromise motor performance. Intracranial self-stimulation (ICSS) of the
medial forebrain bundle is an operant procedure to assess the abuse potential of drugs (Negus
& Miller, 2014). DA receptor antagonists shifted the ICSS frequency-rate curve in the direction
that signifies abuse-limiting effects but did not alter responding rates at maximum frequency
as motor-impairing treatments would (Franklin, 1978). Moreover, DA receptor antagonists did
not immediately affect conditioned responses to rewarding stimuli, such as food or heroin but,
instead, progressively reduced habitual responding over days (Wise & Raptis, 1986; McFarland
& Ettenberg, 1995). These results suggest the DA pathways implicated in motor function,
motivation for acute reward, and reinforcement of reward are dissociable.

However, the mesolimbic and nigrostriatal pathways in fact overlap in their projection targets
and physiological functions, allowing them to complement each other in behavioral outputs
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(Wise, 2009). In the DA-deficient mice, selective restoration of DA signaling in the dorsal
striatum was sufficient to rescue feeding and locomotion (Szczypka et al., 2001; Sotak et al.,
2005). Restoring DA signaling in the NAc did not induce feeding, although it restored
exploratory behavior (Szczypka et al., 2001). DA signaling in the NAc also regulates simple
locomotor behaviors such as running (Zhu et al., 2016). In the classic “reward prediction error”
study, dopamine neurons of both SNc and VTA showed characteristic electrical signals to
reward, reward-predicting stimuli, and reward omission; in fact, the responses were
indistinguishable, and data from the two regions were pooled (Schultz, 1998). Later studies
revealed that a dorsolateral-ventromedial gradient is a better representation of the functional
heterogeneity of DA pathways (Burton et al., 2015). The midbrain-striatum projections are
arranged topographically: SNc projects to the dorsal striatum, the dorsolateral VTA projects to
the lateral shell of the NAc, and the medial VTA projects to the medial shell and core of the
NAc and the prefrontal cortex (Baik, 2020). Progressively from the dorsolateral to the
ventromedial, there is a shift from more sensorimotor function to value encoding (Burton et
al., 2015). It is now accepted that the nigrostriatal and mesolimbic pathways are not distinct
systems, although there are differences. The initiation and expression of goal-directed
behaviors requires the integration of both DA circuits.

Due to the implication of midbrain DA system in motor function, reward, motivation, attention,
and cognition, it is not surprising that DA is involved in many neurological disorders. The
critical role of DA in motor control is exemplified by Parkinson’s disease, a movement disorder
caused be selective degeneration of DA neurons in the SNc (Raza et al., 2019). The motor
symptoms such as rigidity and the non-motor symptoms such as depression and cognitive
impairments are attributed to the loss of DA signaling in the basal ganglia (Chaudhuri &
Schapira, 2009; Raza et al., 2019). DA neurotransmission is involved in all stages of drug
addictions: acute reward, habit-forming, withdrawal, and relapse. Despite their diverse

13
molecular structures and pharmacological mechanisms, drugs of abuse converge on the
reward circuitry to increase DA transmission (Nestler, 2005; Willuhn et al., 2010). After
repeated exposure to drugs, it is hypothesized that conditioned reinforcement and
compulsive drug use involve a switch of control from the “hedonic” NAc to the “habitual”
dorsal striatum (Vanderschuren et al., 2005). The negative affective state of drug withdrawal
has been partially attributed to decreased activities of the mesolimbic DA system (Koob &
Volkow, 2010). Finally, DA neurons respond not just to reward, but also to reward-predicting
conditioned stimuli. Increased DA neuron firing and DA release contribute to cue-evoked
craving and reinstatement of drug-seeking behavior, causing relapse (Koob & Volkow, 2010;
Willuhn et al., 2010). Moreover, some subsets of DA neurons respond to aversive stimuli and
mediate conditioned avoidance behavior (Ilango et al., 2012). While the lethargic and negative
affective state of major depression may reflect decreased DA transmission, some mesolimbic
DA signals promote stress-induced anxiety and depression (Chaudhury et al., 2013; Tye et al.,
2013). In addition, aberrant DA transmission is implicated in attention-deficit hyperactivity
disorder (ADHD), obsessive-compulsive disorder (OCD), and schizophrenia (Del Campo et al.,
2011; Bokor & Anderson, 2014; McCutcheon et al., 2019). Taken the diverse neuromodulatory
roles of DA, understanding the physiological regulation of midbrain DA neurons would
contribute to developing treatments for a variety of nervous system disorders.

There is great interest in the molecular basis of midbrain DA neuron firing patterns, which
tightly control DA release in the striatum. At baseline, DA neurons are pacemakers that exhibit
slow and irregular single-spike activity in vivo which sustains tonic DA levels in the striatum
(Floresco et al., 2003). Upon exposure to reward or reward-predicting stimuli, DA neurons
increase excitability and switch from “tonic” firing to a high-frequency, “phasic” burst firing
pattern (Schultz, 1998; Willuhn et al., 2010). Both increases in single-spike frequency (Floresco
et al., 2003) and burst firing activity (Zweifel et al., 2009) promote striatal DA release;
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nevertheless, burst firing is more effective at doing so. In anesthetized rats, electrical
stimulation that mimicked burst firing pattern caused a two-fold increase in striatal DA release
compared to single-spiking of the same average frequency (Gonon, 1988). In a paradigm that
applied trains of pulses, the evoked DA release increased exponentially with the frequency of
pulses within each train (Gonon, 1988; Chergui et al., 1994). The drastic increase in
extracellular DA levels in the striatum acts as a form of information coding: to signal acute
reward as well as trigger long-term neuroplastic changes that underlie reward conditioning
(Koob & Volkow, 2010; Willuhn et al., 2010). The firing activity of DA neurons – especially the
transition from tonic firing to burst firing pattern – is regulated by excitatory and inhibitory
synaptic inputs from various brain regions. Those include glutamatergic afferents from the
prefrontal cortex and subthalamic nucleus, and mixed glutamatergic and cholinergic afferents
from the mesopontine tegmentum (Kitai et al., 1999; Paladini & Roeper, 2014).

The role of cholinergic inputs in dopamine release and reward behaviors
Acetylcholine (ACh) release from the mesopontine cholinergic nuclei directly regulates the
firing activities of midbrain DA neurons. These nuclei are separated into two anatomically
distinct cell groups, the pedunculopontine tegmental nucleus (PPT) and the laterodorsal
tegmental nucleus (LDT), which provide the sole sources of cholinergic inputs to the midbrain
DA system. The two nuclei are topographically organized, with the PPT mostly projects to SNc,
whereas the LDT predominantly projects to VTA (Cornwall et al., 1990; Oakman et al., 1995).
This innervation pattern suggests that the PPT and the LDT may preferentially modulate motor
and reward behaviors, respectively. Both the PPT and the LDT are heterogenous nuclei
comprising cholinergic, glutamatergic, and GABAergic neurons. Cholinergic cells make up
~25% and ~22% of the total neuronal populations in the PPT and LDT, respectively (Wang &
Morales, 2009; Luquin et al., 2018). Glutamatergic and GABAergic cells are more numerous,
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each making up about one-third of the neurons in both nuclei (Wang & Morales, 2009; Luquin
et al., 2018). Subpopulations co-expressing cholinergic with glutamatergic or GABAergic
markers are also present in both nuclei, but they together are minorities that comprise <10%
of the total populations (Wang & Morales, 2009; Luquin et al., 2018). The lack of cells with
mixed markers suggests that co-release of ACh with glutamate or GABA from the cholinergic
neurons is unlikely, although an electrophysiological study showed that PPT glutamatergic and
cholinergic afferents converge on the same DA neuron (Futami et al., 1995). Subpopulations
of DA neurons may also be selectively targeted by the mesopontine cholinergic projections. It
was found that LDT cholinergic neurons predominantly synapse onto mesoaccumbal DA
neurons but scarcely onto mesocortical DA neurons (Omelchenko & Sesack, 2006). There is
also recent evidence that LDT cholinergic afferents preferentially activate lateral VTA DA
neurons and D1-expressing medium spiny neurons (MSNs) in the NAc core and shell (Coimbra
et al., 2021). Thus, a major role of the LDT-VTA-NAc circuitry in reward and motivational
behaviors has been proposed.

The direct cholinergic inputs excite midbrain DA neurons via activation of both nicotinic
(nAChRs) and muscarinic (mAChRs) receptors. While nAChRs are ligand-gated ion channels
that increase cation conductance, the effects of mAChRs on cell excitability depend on the
subtype. mAChRs subtypes coupled to the Gq pathway (M1, M3, and M5) are generally
excitatory while others coupled to the Gi pathway (M2 and M4) are generally inhibitory.
Notably, midbrain DA neurons express primarily the M5 mAChR subtype. In SNc and VTA
dopaminergic cell bodies of rats, mRNA for the M5 receptor was the only mAChR subtype
detected and was highly co-expressed with the D2 receptor (99% of cells) (Vilaro et al., 1990;
Weiner et al., 1990). Pharmacological probes and antibodies against the M5 receptor protein
showed comparable results (Reever et al., 1997; Garzon & Pickel, 2013). Among the five
mAChR subtypes, M5 has the lowest expression levels and the most restricted pattern
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throughout the brain and peripheral tissues (Weiner et al., 1990; Levey, 1993). This unique
expression pattern predicts that M5 is a locus for selective modulation of DA neurons involved
in abuse-related behaviors, making it an attractive pharmacological target for drug addiction.

Activation of cholinergic receptors on midbrain DA neurons causes DA release in the striatum,
and mAChRs generate a larger, more sustained response than nAChRs. In anesthetized rats,
electrically stimulated Ach release from the LDT elicited a time-dependent triphasic response
as measured by DA levels in the NAc (Forster & Blaha, 2000). Immediately after LDT
stimulation, there was an increase of accumbal DA that is dependent on nAChRs and
ionotropic glutamatergic receptors, followed by a decrease in DA levels that is dependent on
the M2 and M4 autoreceptors on the LDT cholinergic neurons. The third phase was a M5
mAChR-mediated large, slow DA increase that lasted for more than 60 min after stimulation
(Forster et al., 2002). This triphasic response shows that the M5 receptor quantitatively
mediates most of the cholinergic-stimulated DA release. Another in vivo study in mice
demonstrated that muscarinic inputs contribute to 60-70% of accumbal DA release after
electrical stimulation of the LDT, while nicotinic inputs account for about 40% (Lester et al.,
2008; Lester et al., 2010b). Importantly, a related study showed that intra-VTA injection of
mAChR antagonists was able to reverse cocaine-induced accumbal DA elevation back to
baseline levels (Lester et al., 2010a). In the striatum, M5 mAChRs located on the DA axon
terminals also modulate DA release. In agreement with the excitatory action of M5, two
studies showed that activation of axonal M5 mAChRs promotes DA release (Zhang et al., 2002;
Shin et al., 2015). Another study, however, reported the opposite: a reduction of DA release
(Foster et al., 2014). Nonetheless, these studies demonstrated that striatal DA release,
especially in the context of psychostimulant-induced elevation, is largely mediated by mAChRs
on the DA neurons.
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It is well-established that cholinergic activation in the midbrain promotes DA-driven behaviors.
As predicted by their anatomical segregation, optogenetic activation of PPT terminals in the
SNc selectively increased locomotion, whereas activation of LDT terminals in the VTA
selectively increased reward responses (Xiao et al., 2016). Rats self-administrated and showed
conditioned place preference (CPP) for direct VTA infusions of the cholinergic agonist
carbachol (Ikemoto & Wise, 2002). Lesion of LDT, but not PPT, cholinergic neurons significantly
prolonged latencies to initiate cocaine self-administration (Steidl et al., 2014; Steidl et al.,
2015). Intra-VTA infusions of cholinergic antagonists also reduced cocaine- and morphineinduced locomotion and reward effects (Rezayof et al., 2007; Steidl & Yeomans, 2009; Solecki
et al., 2013). Taken together, these results suggested that activation of cholinergic receptors
in the VTA is crucial for the development of addiction-related behaviors. The causal role of
VTA cholinergic signaling in drug-induced reward conditioning was demonstrated by in vivo
microdialysis (You et al., 2008): in cocaine-withdrawn rats, cue-evoked drug-seeking
correlated with a robust increase of ACh release in the VTA. Drug-seeking behavior was
increased by intra-VTA administration of a cholinesterase inhibitor that increased ACh levels,
attenuated by a nicotinic antagonist, and completely blocked by a muscarinic antagonist.
Notably, the stronger effects of muscarinic blockage on inhibiting drug seeking correlates with
the larger contribution of muscarinic inputs in inducing NAc DA release.

In vivo genetic and pharmacological studies confirmed the importance of M5 signaling in DAmediated behaviors. M5 receptor knockout (KO) completely abolished the largest, slowest
phase of cholinergic-stimulated striatal DA release described above (Forster et al., 2002). In
behavioral assays, M5 KO mice exhibited significantly reduced cocaine- and morphine-induced
locomotion, CPP, self-administration, and withdrawal (Basile et al., 2002; Fink-Jensen et al.,
2003; Thomsen et al., 2005; Steidl & Yeomans, 2009). Systemic administration of ML375, a
novel M5-selective negative allosteric modulator, also attenuated self-administration of
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cocaine, ethanol, and opioids at doses that did not significantly affect locomotion (Berizzi et
al., 2018; Gunter et al., 2018; Gould et al., 2019). Moreover, intra-VTA administration of an
ML375 analogue reversed the pro-depressive and anxiogenic effects of cholinergic excess in
this brain region (Nunes et al., 2020). In summary, mAChRs expressed on the VTA DA neurons
mediate a constellation of behaviors driven by dopaminergic neurotransmission, including
locomotion, acute reward, drug-seeking, drug withdrawal, anxiety, and depression. However,
while evidence provided by biochemical and behavioral studies is strong, information on how
mAChRs modulate DA neuron firing is lacking. The next section discusses the
electrophysiological mechanisms downstream of cholinergic signaling in midbrain DA neurons.

Cholinergic signaling and regulation of dopamine neuron firing
mAChRs are G protein-coupled receptors (GPCR) that rely on intracellular signaling
transduction and modification of ion channel activity to alter neuronal firing. Therefore, the
opening or closing of one or multiple ion channels must underlie the increased excitability
mediated by mAChRs in midbrain DA neurons. As previously mentioned, the M5 receptor
follows the pattern for the odd-numbered mAChR subtypes – M1, M3, and M5 are coupled to
the Gq pathway, which results in activation of phospholipase C- (PLC), phosphatidylinositol
4,5-bisphosphate (PIP2) hydrolysis, increase in diacylglycerol (DAG), Ca2+ store release, and
activation of protein kinase C (PKC) (Brown, 2018). Lacey et al. (1990) were among the first to
demonstrate muscarinic actions in midbrain DA neurons were mediated by M1-like receptors.
In acute slice preparations, bath perfusion of muscarine induced an TTX- and Cs+-insensitive
inward current, which corresponded with depolarization of membrane potential and an
increase in pacemaking frequency. These excitatory effects were attenuated by the M1-like
mAChR antagonist pirenzepine. Burst firing or depolarization block was not observed with the
muscarine treatment. Interestingly, the muscarinic excitation was accompanied by a decrease
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in membrane conductance between −50 and −65 mV but an increase in conductance between
−40 and −50 mV. In addition, although muscarine reduced the amplitude of
afterhyperpolarization (AHP), this effect was reversed by the injection of hyperpolarizing
current. Accordingly, Lacey et al. suggested that mAChRs in midbrain DA neurons act by
decreasing a potassium conductance, but an additional “leak-like” conductance is also
involved.

The theory that potassium conductance was involved in muscarinic excitation of midbrain DA
neurons was further elaborated by Kitai and colleagues, as deduced from mesopontine
afferent modulation of DA neuron firing activities (Kitai et al., 1999). At the time, it was
established that activation of NMDA receptors is the major mechanism of burst generation in
DA neurons. The conversion of in vivo firing patterns to in vitro pacemaking was ascribed to
deafferentation of excitatory inputs, such as from the PPT. It was also evident that other
mechanisms are involved in burst generation. Notably, inhibition of small conductance
calcium-activated potassium (SK) channels induces bursting and facilitates NMDA-induced
bursting. Along with the results from Lacey et al. showing decreased membrane conductance,
Kitai and colleagues proposed that mAChRs in DA neurons suppress SK current and act in
conjunction with glutamatergic inputs to increase excitation. In support of this hypothesis, an
in vivo study by Lodge and Grace (2006) showed that the absence of mesopontine inputs
resembled the effects of SK channel activation: pharmacological inhibition of the LDT
abolished NMDA-induced bursting and caused regularization of tonic firing pattern in VTA DA
neurons, suggesting mAChRs may tonically inhibit SK current. However, when other studies
identified the critical role of 2-containing nAChRs in burst firing in DA neurons, a new theory
emerged that nAChRs are responsible for the cholinergic control of firing mode switch
(Maskos, 2008; Faure et al., 2014).
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Chen and coworkers provided the first evidence that a specific ion channel mechanism
underlies muscarinic excitation of DA neurons. Using acute slice preparations, they showed
that carbachol increased the pacemaking frequency in the majority of VTA DA neurons and
induced burst firing in 20% of the cells (Zhang et al., 2005). Those actions were due to
combined activation of nAChRs and mAChRs. In the presence of TTX, carbachol elicited
membrane potential oscillations that had similar time course to carbachol-induced burst
cycles. The oscillations were sensitive to Cd2+ and nifedipine, implicating L-type Ca2+ channels.
In subsequent studies, they showed that carbachol caused a modest increase of L-type Ca2+
current via PKC activation (Liu & Chen, 2008). In summary, works by the Chen Lab
demonstrated that PKC-dependent activation of L-type Ca2+ channels is involved in the
cholinergic switch of tonic to burst firing in DA neurons. Nonetheless, their results also showed
that L-type Ca2+ current was not the only conductance modulated by mAChRs, as carbachol
still induced a slow depolarization and an increase in pacemaking frequency in the presence
of Cd2+, nifedipine, or PKC inhibitors.

A more recent study by Foster et al., (2014) supported the receptor specificity and the
involvement of Gq signaling in M5 mAchR-mediated excitation of DA neurons. In their
experiments using acute slice preparation, the non-selective mAChR agonist oxotremorine-M
induced a TTX-insensitive inward current that coincided with Ca2+ store release in SNc DA
neurons – effects that were consistent with Gq activation. In spontaneously firing cells,
oxotremorine-M caused an increase in pacemaking frequency and a slight broadening of AP
width. These effects were potentiated by a M5-selective positive allosteric modulator and
were absent in M5 KO mice. Although these results confirmed that the M5 mAChR mediates
most, if not all, of the excitatory effects in DA neurons, the ionic mechanisms were not
explored. Taken together, the evidence hitherto showed that (1) nAChRs and mAChRs both
and independently contribute to cholinergic excitation of midbrain DA neurons, (2) mAChRs
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induce membrane potential depolarization and an increase in firing frequency, and (3)
mAChRs likely contribute to the tonic-burst firing mode switch. However, the results across
studies were nebulous and complex – no consensus has been reached on the precise
electrophysiological effects of mAChR activation, and it is likely that more than one ion
channel mechanism is involved. This gap in the knowledge calls for a more thorough
characterization of the electrical mechanisms underlying muscarinic excitation of midbrain DA
neurons. The next section reviews ion channel mechanisms in the regulation of midbrain DA
neuron excitability, especially in the context of modulation by Gq signaling.

Ion channel regulation of midbrain dopamine neuron activity

Ionotropic receptors (glutamatergic, GABAergic, and nicotinic receptors)
The in vitro pacemaking and in vivo bursting of midbrain DA neurons are generated by
different sets of ion channels. As previously discussed, DA neurons in vivo exhibit two distinct
firing patterns: a low-frequency tonic background activity (1-8 Hz) and transient highfrequency bursting (>15 Hz) (Roeper, 2013; Paladini & Roeper, 2014). A common criterion to
define bursts is a minimum of three spikes, starting with an interspike interval (ISI) <80 ms and
ending with a pause ISI >160 ms (Paladini & Roeper, 2014). The generation of burst firing
requires synaptic inputs and can be modulated by multiple neurotransmitter systems. This can
be achieved by activation of post-synaptic ionotropic glutamate receptors, GPCR-mediated
reductions in AHP, or activation of other cationic channels (Johnson & Wu, 2004; Blythe et al.,
2007). In contrast, when synaptic inputs are absent, as in neuronal cultures or acute brain
slices, DA neurons are incapable of bursting but retain the intrinsic ion channel mechanisms
to maintain a highly regular, low-frequency pacemaking activity (Grace & Onn, 1989; Khaliq &
Bean, 2010; Roeper, 2013).
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The current “dual control model” states that the ionic conductance in DA neurons in vivo exists
in a dynamic equilibrium between excitatory (i.e., glutamatergic) and inhibitory (i.e.,
GABAergic) inputs: bursts can be generated by either increasing NMDA receptor (NMDAR) or
decreasing GABAA receptor (GABAAR) stimulation (Paladini & Roeper, 2014). Accordingly, the
application of intra-midbrain NMDA to anesthetized animals results in bursting of DA neurons
(Zhang et al., 1994), while NMDAR antagonists or selective KO of NMDAR in DA neurons
disrupted bursting (Zweifel et al., 2009). Activation of AMPA/kainate receptors produced
similar effects: increased tonic firing frequency and burst firing (Zhang et al., 1994). In this
context, the modulation of fast inhibitory inputs via GABAAR is also proposed to be a major
mechanism of firing mode switch. These mechanisms allow DA neurons to quickly switch
between tonic and burst firing modes in response to behaviorally salient events.

Nicotinic acetylcholine receptors (nAChRs) provide another major source of excitation and
firing pattern control of midbrain DA neurons. In general, opening of nAChRs increases
excitation by conducting non-selective cationic current (Picciotto et al., 2012). Several
characteristics of nAChRs further allow for exquisite spatial and temporal modulation of
neuronal behaviors. First, the biophysical properties of nAChRs differ among subunit
compositions. Neuronal nAChRs comprise 5 subunits that can be either a heteromeric
combination of  and  subunits or homomeric with the 7 subunit (Faure et al., 2014).
Midbrain DA neurons are enriched in the 4, 5, 6, 2, and 3 subunits (Klink et al., 2001;
Faure et al., 2014). The heteromeric 42-containing (a third subunit is possible) nAChRs have
high affinity for Ach and play a major role in drug reinforcement, especially nicotine (Faure et
al., 2014). The low-affinity, homomeric 7-nAChRs are also present in a minority of VTA DA
neurons, while they are rare in SNc DA neurons (Klink et al., 2001; Wooltorton et al., 2003;
Faure et al., 2014). In acute brain slices, bath perfusion of nicotine (10 μM) caused a 7.7 mV
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depolarization and increased pacemaking frequency of SNc DA neurons (Matsubayashi et al.,
2003). In the voltage-clamp configuration holding at −60 mV, bath perfusion of nicotine (10
μM) induced an inward current with the saturation peak amplitude of −28.3 pA (Matsubayashi
et al., 2003). Most of the current was inhibited by the 42 subtype-selective antagonist
DHE. Similarly, Ach-induced nAChR currents in VTA DA neurons were greatly reduced in 4
KO and completely absent in 2 KO mice (Klink et al., 2001). Those studies indicated that 42
is the predominant functional subtype in midbrain DA neurons.

Second, nAChRs undergo desensitization with prolonged exposure to agonists; the propensity
to desensitize also differs among nAChR subtypes (Faure et al., 2014). After an initial activated,
conducting state upon agonist binding, nAChRs change into a desensitized conformational
state in which the channels are closed while the agonist is still bound to the nAChRs (Brunzell
et al., 2014). Heteromeric nAChRs are the high-affinity, slow-desensitizing subtypes, whereas
the homomeric 7-nAChRs are the low-affinity, fast-desensitizing (Brunzell et al., 2014). Due
to their high affinity to agonists, 42-containing nAChRs are more readily desensitized
compared to 7-nAChRs when exposed to the same low concentration of agonists. Midbrain
DA neurons depolarize and increase firing frequency acutely when exposed to low
concentrations of nicotine (80-500 nM) in the brain slice preparation. This response is
completely desensitized within a few minutes (Pidoplichko et al., 1997; Wooltorton et al.,
2003; Pidoplichko et al., 2004). In contrast, 7-nAChRs are more resistant to desensitization
by agonists of similar concentrations due to their low affinity (Wooltorton et al., 2003). 7nAChRs are preferentially localized on the glutamatergic terminals that synapse onto DA
neurons (Jones & Wonnacott, 2004). While the native nAChRs on DA neurons are desensitized,
nAChR agonists can excite DA neurons by enhancing glutamatergic EPSCs (Pidoplichko et al.,
2004). Interestingly, the same treatment transiently enhanced but depressed IPSCs in VTA DA
neurons after several minutes (Pidoplichko et al., 2004). This suggested nAChRs on GABAergic
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neurons that synapse onto DA neurons exhibit a similar time course of desensitization and
ultimately contribute to disinhibition of DA neurons. Finally, the effects of nAChR activation
depend on its location on the neuron (Picciotto et al., 2012). nAChRs on the dendrites and
soma of DA neurons serve as excitatory postsynaptic inputs that regulate firing activity, while
nAChRs on the axonal terminals in the striatum regulate DA release (Exley et al., 2008; Exley
et al., 2012).

Activation of nAChRs in DA neurons, especially in synergy with other synaptic inputs, is
involved in cholinergic induction of burst firing. A direct role of nAChRs in burst generation
was shown by Zhang et al. (2005): burst firing was induced in a subset of VTA DA neurons in
brain slices via activation of 42 nAChRs alone. However, because burst firing is usually
absent in vitro, the majority of studies were done by observing in vivo KO phenotypes or
administrating nAChR agonists to anesthetized animals. It was established that the 2 subunit
has the most critical role permitting burst firing. The in vivo firing pattern of VTA DA neurons
from 2 KO mice resembled in vitro pacemaking: having reduced firing rates and lacking
spontaneous bursting (Mameli-Engvall et al., 2006). Single KO of the  subunits showed no
differences in spontaneous activity in vivo (Exley et al., 2011; Morel et al., 2014). However,
only 4 KO and 2 KO abolished nicotine-induced bursting, corroborating 42 as the main
nAChR mediating drug reinforcement (Mameli-Engvall et al., 2006; Exley et al., 2011).
Interestingly, spontaneous bursting and nicotine-induced bursting of DA neurons only
occurred when 2 was present on both VTA DA and GABA neurons; this highlighted the
importance of simultaneous inhibitory inputs (Tolu et al., 2013). Together, these results were
crucial to the development of the hypothesis that cholinergic inputs play a permissive role in
burst firing. The nicotinic effect appears to be a network mechanism that primes DA neurons
for the glutamatergic drives and the GABAergic pauses.
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Voltage-gated sodium and calcium channels
Midbrain DA neurons are particularly susceptible to depolarization block, which restricts their
maximum tonic firing frequency. Upon moderate excitation, there is a gradual shortening of
AP amplitude, broadening of AP width, increase in AP threshold, and decrease in AHP
amplitude that eventually leads to failure of AP generation (Richards et al., 1997; Tucker et al.,
2012). Voltage-gated sodium (Nav) channels are involved in both AP initiation and
depolarization block. The alterations in AP shape associated with decreased Nav channel
availability can be induced by either a +250 pA current injection or addition of NMDAR
conductance using dynamic clamp (Tucker et al., 2012). Mechanistically, depolarization block
results from accumulative inactivation of Nav channels. Treatment with a low concentration
of tetrodotoxin (TTX, 10 nM), which causes partial inhibition of Nav channels, recapitulated
the alterations in AP shape and increased susceptibility to depolarization block (Tucker et al.,
2012). Conversely, addition of somatic Nav channel conductance via dynamic clamp reversed
the alternations in AP shape and prevented depolarization block (Tucker et al., 2012).
Moreover, somatic Nav channel conductance contributes to the slow depolarization during ISI
and is linearly proportional to pacemaking frequency (Tucker et al., 2012). In situ hybridization
(Gonzalez-Cabrera et al., 2017) and immunohistochemical studies (Yang et al., 2019) showed
that midbrain DA neurons predominantly express the Nav1.2 subunit. Compared to the more
abundant Nav1.6 in the adult brain, Nav1.2 activates at more depolarized potentials and
inactivates faster; these properties may explain the high AP threshold and susceptibility to
depolarization block in DA neurons. Therefore, even though the AP is initiated in the axonal
initial segment, somatic Nav channels, likely Nav1.2, control the balance between pacemaking
frequency and depolarization block in midbrain DA neurons.

The mechanism of pacemaking generation in SNc DA neurons depends largely on the activity
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of voltage-gated calcium (Cav) channels. Midbrain DA neurons express the Cav1.2 and Cav1.3
subtypes of L-type calcium channels; in both SNc and VTA Cav1.3 is expressed at higher levels
(Takada et al., 2001; Rajadhyaksha et al., 2004; Chan et al., 2007). Compared to Cav1.2, Cav1.3
has a lower activation threshold (V1/2 = −40.4 mV) (Lipscombe et al., 2004). Current flowing
through Cav1.3 channels is activated at subthreshold voltages during the ISI and helps drive
membrane potential to the spike threshold (Puopolo et al., 2007; Putzier et al., 2009). In the
presence of TTX, this subthreshold calcium current produces slow membrane potential
oscillations that can reach 15 mV in SNc DA neurons (Kang & Kitai, 1993; Zhang et al., 2005;
Chan et al., 2007). The slow oscillations occur at membrane potentials between −50 and −38
mV and can be eliminated by the non-selective calcium channel blocker Cd2+ (100-400 M) or
dihydropyridine blockers (Kang & Kitai, 1993; Zhang et al., 2005). In comparison, VTA DA
neurons show very small (<5 mV) or no Ca2+-mediated membrane potential oscillations in TTX
and rely on additional mechanisms to drive pacemaking (Chan et al., 2007; Khaliq & Bean,
2010). It is noteworthy that the repolarization and hyperpolarization phase of the oscillations
requires a TEA- and apamin-sensitive Ca2+-activated potassium conductance, indicating SK
channel activities (Kang & Kitai, 1993; Ping & Shepard, 1996). Therefore, the activities of Cav
channels and SK channels are definitely linked to attain pacemaking and regulate firing
patterns in these neurons (Johnson & Wu, 2004).

Activation of Cav channels is also involved in burst generation in midbrain DA neurons. Studies
showed that L-type calcium channel activators induced burst firing of VTA DA neurons in brain
slices (Johnson & Wu, 2004; Zhang et al., 2005; Liu et al., 2014). The burst firing consists of a
rhythmic cycle of two or more spikes with high frequency followed by a post-burst
hyperpolarization; the average frequency of burst cycles was around 0.06-0.12 Hz (8-17
seconds per cycle) (Liu et al., 2014). Dynamic clamp experiments showed that adding a virtual
Cav1.3 conductance did not produce burst firing on its own, but it increased the frequency of
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burst firing induced by a virtual NMDA receptor conductance. Like the generation of
pacemaking, the amplification of bursting frequency required the specific voltage
dependence (V1/2) of Cav1.3 rather than the Ca2+ entry (Putzier et al., 2009). SNc and VTA DA
neurons also highly express the Cav3.1 isoform of T-type calcium channels (Poetschke et al.,
2015; Tracy et al., 2018). T-type Cav channels have a low activation threshold (V1/2 = −59.6 mV)
and inactivate at depolarized potentials, making them ideally situated to regulate firing
pattern (Tracy et al., 2018). In subsets of SNc and VTA DA neurons, a period of
hyperpolarization could relieve inactivation of Cav3.1 channels and produce rebound burst
firing (Evans et al., 2017; Tracy et al., 2018). These rebound-ready DA neurons also showed
higher tonic firing frequency and larger HCN voltage sag, suggesting an interplay between Ttype Cav channels and HCN channels to promote excitation (Evans et al., 2017). Together, the
subthreshold calcium current through both L-type and T-type Cav channels enables
membrane potential oscillations, which underlie the rhythmic pacemaking activity as well as
rebound burst firing in midbrain DA neurons.

HCN channels
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are voltage-gated nonselective cation channels that provide a depolarizing current in response to membrane
hyperpolarization (Chu & Zhen, 2010). Midbrain DA neurons exhibit very prominent HCN
currents and HCN-mediated “voltage sag”, with the average amplitudes larger in the SNc
compared to the VTA (Masi et al., 2015; Krashia et al., 2017). This unusually large HCN
activation is an important feature to identify DA neurons. Virtually all SNc DA neurons and
98% of TH-positive VTA DA neurons exhibit HCN activity (Wanat et al., 2008; Chu & Zhen, 2010;
Roeper, 2013), except a subpopulation of DA neurons in the ventromedial VTA that lack HCN
channel expression (Roeper, 2013; Masi et al., 2015). On the contrary, GABAergic interneurons
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of the VTA in mice exhibit very little or no HCN activity (Chieng et al., 2011). The HCN channel
is a major regulator of membrane potential in DA neurons. The 4 HCN subunits vary
considerable in their gating kinetics and cAMP sensitivity (Chu & Zhen, 2010). Midbrain DA
neurons express the HCN2, HCN3, and HCN4 subunits, which are highly sensitive to cAMP and
have a slow activation time constant ranging from 0.5 to 5 s at −120 to −80 mV (Franz et al.,
2000). The slow activation kinetics suggest that HCN channels would remain active and
depolarize the average membrane potential in pacemaking cells. Indeed, pharmacological
blockage of HCN channels in SNc DA neurons resulted in a strong hyperpolarization of 11.8
mV and cessation of firing (Gambardella et al., 2012). When the membrane potential change
was compensated by current injection, pacemaking activity was recovered (Gambardella et
al., 2012). This suggested that HCN channels do not participate in the generation of
pacemaking in DA neurons. HCN channels also regulate the shape of AHP (Neuhoff et al., 2002;
Okamoto et al., 2006; Wanat et al., 2008). After a single AP or a burst, DA neurons exhibit a
prolonged AHP that often exceeds −70 mV. The hyperpolarization activates HCN channels,
which drive the membrane potential back to the AP threshold. Therefore, enhancement of
HCN activity will reduce the amplitude and duration of AHP, speed up pacemaking frequency,
decrease rebound latency and, thus, increase the overall excitability of DA neurons.

HCN channels are directly gated by cAMP and are sensitive to many intracellular factors such
as PIP2 and protein kinases downstream of GPCRs (Chu & Zhen, 2010). It is predicted that Gscoupled GPCRs would enhance HCN currents by stimulating adenylyl cyclase activity and
cAMP production, while Gi-coupled GPCRs would have the opposite effect via inhibition of
adenylyl cyclase and the reduction of cAMP levels. In addition, HCN channels are inhibited by
PKC activation downstream of Gq signaling. Serotonin and dopamine inhibit HCN channels
and decrease excitability in DA neurons via activation of 5-HT2 (Gq-coupled) and D2 (Gicoupled) receptors, respectively (Liu et al., 2003; Gambardella et al., 2012). However,
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regulation of HCN by PKC is complex, perhaps due to different PKC isoforms. The neuropeptide
corticotropin-releasing factor (CRF) enhanced HCN currents and increased the pacemaking
frequency of VTA DA neurons via a PLC/PKC-dependent mechanism (Wanat et al., 2008).
Activation of the Gq-coupled α1-adrenoceptor also resulted in increased HCN currents and
pacemaking frequency of DA neurons (Gambardella et al., 2012; Goertz et al., 2015). The
signaling mechanisms responsible for this norepinephrine-induced effect are unknown. In
summary, many neurotransmitters activate signaling pathways that have HCN channels as
effectors, resulting in the modulation of DA neuron electrical activity.

Calcium-activated potassium channels (SK and BK channels)
One feature of midbrain DA neurons is a large and prolonged AHP. Following each action
potential, the AHP on average has an amplitude of −22.1 mV, hyperpolarizes to −63.6 mV, and
takes 330 ms to return to resting levels (Shepard & Bunney, 1991; Richards et al., 1997; Wanat
et al., 2008). The AHP has a fast and a medium/slow component. In midbrain DA neurons, the
medium/slow phase of AHP – the most hyperpolarized point – is mediated by the SK channel
(Shepard & Bunney, 1991; Ping & Shepard, 1996). SK channels in central neurons are coded
by the SK1-3 (KCa2.1-KCa2.3) genes (Stocker, 2004; Faber & Sah, 2007). Midbrain DA neurons
express SK2 and SK3, with SK3 being the predominant subunit (Wolfart et al., 2001; Deignan
et al., 2012). Although structurally similar to the voltage-gated potassium channels, SK
channels are voltage-insensitive due to the loss of positive charges on the S4 voltage sensor
domain (Stocker, 2004). Instead, SK channels are gated only by intracellular Ca2+ that enter
the cells through Cav channels upon depolarization. The opening of SK mediates potassium
conductance that hyperpolarizes the membrane to below baseline potentials, both allowing
the recovery of other voltage-gated channels from inactivation and maintaining the rhythm
of the pacemaking activity. SK channels are highly sensitive to Ca2+ with a Kd of 300 to 700 nM
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(Stocker, 2004). The high affinity of Ca2+ allows SK channels to be regulated by a variety of Ca2+
sources, including Cav channels, NMDAR, nAChR, and GPCR-mediated store release (Faber &
Sah, 2007). Among the Cav channel subtypes, SK activities in midbrain DA neurons are tightly
coupled to T-type and N-type, while L-type channels are thought to play a much lesser role
(Wolfart & Roeper, 2002; de Vrind et al., 2016; Estep et al., 2016).

Because the AHP determines the timing of the next AP, the SK channel is a potent regulator
of both AP shape and firing pattern in midbrain DA neurons. Notably, inhibition of SK activity
is involved in the generation of in vivo burst firing and in vitro electrical changes associated
with burst firing. Negative modulation of SK in anesthetized animals increased firing rates and
converted regular spiking to bursting, while activation of SK decreased both firing rates and
burst firing (Herrik et al., 2010). Correspondingly, the selective SK channel blocker apamin
(100-300 nM) increased the pacemaking frequency and decreased firing regularity of DA
neurons in brain slices, as quantified by both a decrease in the average ISI and an increase of
the CoV of the ISI from 0.05 to 0.30 (Wolfart et al., 2001; Deignan et al., 2012). A detailed
analysis using genetic KO mice revealed differential regulation by the subunits: SK2 regularizes
firing pattern, while SK3 decreases firing frequency (Deignan et al., 2012). In a current step
protocol, apamin significantly reduced the kinetics of AHP, increased the slope of frequencycurrent (f-I) relationship, and increased the spike frequency adaptation (SFA) ratio (Shepard &
Bunney, 1991; Vandecasteele et al., 2011). Both AHP kinetics (amplitude and duration) and
the AHP current were negatively correlated with the SFA ratio (Vandecasteele et al., 2011).
These results confirmed that SK activities regularize firing pattern and make the neurons less
adapting by mediating a larger AHP. Therefore, inhibition of SK channels will produce the
opposite effects, increasing adaptation and shifting the firing to a burst-like pattern.

In midbrain DA neurons, GPCRs are known to modulate SK channel activities. Transient
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activation of group I mGluRs and mAChRs causes opening of SK channels through Gqmediated Ca2+ store release (Fiorillo & Williams, 1998, 2000; Kramer & Williams, 2016). With
sustained activation, the SK-mediated hyperpolarization is replaced by a more commonly
reported depolarizing response (Fiorillo & Williams, 1998, 2000); this biphasic response may
be a common effect of Gq signaling in DA neurons. Besides activation by Ca2+, SK channels are
PIP2-sensitive and possess multiple phosphorylation sites, which allow modulation by protein
kinases. Activation of the α1-adrenoceptor increased tonic firing frequency and burst firing of
midbrain DA neurons partly due to inhibition of SK channels (Goertz et al., 2015). In the
hippocampal CA1 pyramidal neurons, the M1 mAChR inhibits SK channels via a PKC(Buchanan et al., 2010) or casein kinase 2 (CK2)-dependent mechanism (Giessel & Sabatini,
2010). However, knowledge on Gq-mediated protein kinase regulation of SK channels in DA
neurons is lacking. It is unknown whether the Gq-coupled α1-adrenoceptor signals through
the same mechanisms. On the other hand, activation of the Gi-coupled GABAB receptors was
shown to suppress SK currents in SNc DA neurons via inhibition of adenylyl cyclase and PKA
(Estep et al., 2016). The interesting implication of this study is that transient GABAergic inputs
can increase DA neuron excitability: co-activation of GABAA and GABAB receptors, the latter
inhibit SK channels, could promote a pause-burst pattern of firing.

The fast phase of AHP, which corresponds to AP repolarization, is mediated by large
conductance Ca2+-activated potassium (BK) channels and some voltage-gated potassium
channels (Maylie et al., 2004; Faber & Sah, 2007). BK channels are encoded by a single gene,
KCa1.1. Unlike the voltage-insensitive SK channels, BK channels open in response to
depolarization and an increase in intracellular Ca2+, which acts allosterically to shift the
activation voltage (Su et al., 2010; Vandael et al., 2010). In pacemaker cells, BK channels are
often coupled to L-type Cav1.3 channels and effectively control the fast AP repolarization and
firing frequency (Vandael et al., 2010). In SNc DA neurons, BK channels account for 38% of the

32
depolarization-induced potassium current (Kimm et al., 2015). Pharmacological blockage of
BK channels increased pacemaking frequency and widened AP, but had no effects on the slope
of f-I relationship and paradoxically deepened the AHP (Kimm et al., 2015). It was proposed
that this paradoxical increase in AHP arose from recruitment of the slower-activating Kv2
channels when the fast BK-mediated repolarization was absent. Due to its Ca2+ sensitivity, BK
channels can theoretically be modulated by Gq-coupled GPCRs. For example, α1adrenoceptors decreased GABAergic inputs to VTA DA neurons via PKC-dependent activation
of BK channels (Velasquez-Martinez et al., 2015). However, no studies have demonstrated
GPCR modulation of BK channels in midbrain DA neurons.

Kv7 (KCNQ) channels
Kv7 (KCNQ) channels are voltage-gated potassium channels that are regulated by GPCRs.
Muscarinic inhibition of the Kv7 channels was the first discovered GPCR-mediated regulation
of ion channels and was termed the “M-current” (Delmas & Brown, 2005). Activation of Gqcoupled mAChRs depletes membrane PIP2, a necessary co-factor, and thus closes the channels
(Delmas & Brown, 2005). PKC, a downstream effector of Gq signaling, also directly
phosphorylates and inhibits Kv7 channels (Delmas & Brown, 2005). The result is a decrease in
potassium conductance that reduces outward current and depolarizes membrane potential.
The M1, M3, and M5 mAChRs inhibit Kv7 current with equal efficacy in a heterologous
expression system (Guo & Schofield, 2003). In addition to mAChRs, other GPCRs including 5HT2, P2Y, substance P, mGluR, and opioid receptors also inhibit Kv7 channels (Greene & Hoshi,
2017). However, despite the prominent expression and functional consequences of Kv7
activity, there are no studies describing a GPCR-mediated modulation of Kv7 channels in
midbrain DA neurons. Several unique biophysical properties of Kv7 channels make them
potent regulators of neuronal excitability; Kv7 channels have a very negative activation
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threshold around −60 mV, do not inactivate, and exhibit slow activation and deactivation
kinetics (Selyanko et al., 2000). These properties suggest that Kv7 channels maintain a low
level of activity when the neuron is quiescent or firing tonically. Upon excitation, a train of
burst firing will strongly activate the Kv7 channels as a negative feedback mechanism to
hyperpolarize the neuron. Furthermore, Kv7 channels mediate the medium/slow phase of
AHP (Stocker, 2004; Koyama & Appel, 2006; Mateos-Aparicio et al., 2014; Greene & Hoshi,
2017). The presence of Kv7 currents also rises AP threshold and decreases input resistance
(Mateos-Aparicio et al., 2014). Conversely, inhibition of Kv7 channels may excite the neuron
by depolarizing membrane potential, shortening the AHP, promoting burst firing, and
enhancing excitatory synaptic integration.

The Kv7 channel is an important regulator of firing pattern in midbrain DA neurons. Out of the
five Kv7 subunits, VTA DA neurons mainly express Kv7.4 (KCNQ4) – a rare subunit whose
expression is restricted to the midbrain and the auditory pathway – with minor expression of
Kv7.2, 7.3, and 7.5 (Hansen et al., 2006; Li et al., 2017). In contrast, SNc DA neurons mainly
express Kv7.2 and 7.3, with minority subpopulations expressing 7.4 and 7.5 (Li et al., 2017).
Conflicting effects of Kv7 channel blockage on DA neuron excitability have been reported. One
study showed that inhibition of Kv7 channels increased pacemaking frequency and promoted
in vivo burst firing (Sotty et al., 2009), while another reported no effects on in vivo firing
pattern or in vitro recordings of membrane potential (Drion et al., 2010). Similarly, one study
showed that pharmacological blockage of Kv7 channels reduced the fast and slow component
of AHP without changes in AP amplitude, duration, and threshold (Koyama & Appel, 2006),
while another reported no effects on AP shape with the same treatment (Hansen et al., 2006).
The gating properties of Kv7 may provide an explanation for the inconsistent effects of channel
blockage. The Kv7.4 homomeric channels and the Kv7.2/7.3 heteromeric channels both have
a rather depolarized V1/2 of around −18 mV (Selyanko et al., 2000) and slow gating kinetics.
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Therefore, the Kv7 channels may not be substantially activated during the pacemaking activity
of DA neurons. Indeed, the excitatory effect of Kv7 inhibition became more apparent during
high-frequency firing induced by depolarizing current injection or SK channel inhibition, when
a larger population of Kv7 channels would be open (Hansen et al., 2006; Drion et al., 2010).
This suggests that Kv7 inhibition will work synergistically with other excitatory inputs to
promote excitation in DA neurons.

Other voltage-gated potassium channels
Midbrain DA neurons (on the somatodendritic compartments) express voltage-gated
potassium channels including Kv4.3, which constitutes the “A-type” channels, Kv1.3, Kv2.1,
Kv3.2, Kv3.3, which constitute the delayed rectifiers (Dufour et al., 2014), and Kv11, the ethera-go-go-related gene (ERG) potassium channels (Ji et al., 2012). In general, inhibition of Kv
channels decreases potassium conductance and increases intrinsic excitability. Kv2 channels
account for 36% of the depolarization-induced potassium current in SNc DA neurons (Kimm
et al., 2015). Pharmacological inhibition of Kv2 channels caused an increase in pacemaking
frequency in brain slices, a widening of AP, and a reduction of AHP (Kimm et al., 2015). When
fast firing was evoked by a depolarizing current step, Kv2 inhibition significantly increased the
slope of f-I relationship and the propensity to enter depolarization block (Kimm et al., 2015).
Blockage of ERG Kv channels also increased spontaneous pacemaking frequency, f-I
relationship, and the propensity to enter depolarization block of midbrain DA neurons in brain
slices, but it had no effects on SFA and AHP (Ji et al., 2012). Therefore, the general actions of
Kv channels are to oppose the inward currents during spiking and slow pacemaking frequency.

The spontaneous firing of midbrain DA neurons is limited to low frequencies partially due to
the prominent A-type current, which exerts a powerful control on intrinsic excitability. Those
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potassium channels are named after their sensitivity to 4-aminopyridine (4-AP) but are
resistant to TEA (Liss et al., 2001; Khaliq & Bean, 2008; Xue et al., 2020). The fast-inactivating
A-type current is the dominant depolarization-induced potassium current in midbrain DA
neurons (Liss et al., 2001). Having a low activation threshold, A-type channels activate and
inactivate at subthreshold voltages, providing a large outward current that significantly
prolongs the ISI and delays spiking (Khaliq & Bean, 2008). In midbrain DA neurons, the main
mediator of A-type potassium current is Kv4.3. The levels of Kv4.3 expression and A-type
current density are inversely correlated with the pacemaking frequency of SNc DA neurons
and are sufficient to explain the variation in spontaneous firing rates among DA neurons (Liss
et al., 2001). A recent study demonstrated endocannabinoid-mediated inhibition of A-type
current, linking Gq signaling to modulation of DA neuron excitability (Gantz & Bean, 2017).
Upon activation of Gq-coupled GPCRs, the endocannabinoid 2-arachidonoylglycerol (2-AG) is
generated from its precursor DAG via diacylglycerol lipase activity (Katona & Freund, 2012).
Activation of mGluRs, neurotensin, and orexin receptors effectively inhibited A-type current
in SNc DA neurons via 2-AG generation. This resulted in an increase in pacemaking frequency
and the slope of f-I relationship independent of cannabinoid receptors, suggesting a direct
effect of 2-AG on the ion channels. Alternatively, Gq signaling may also inhibit A-type current
in DA neurons via activation of PLC/PKC, as in the case of GHS-R1a, a G protein-coupled
receptor of the hormone ghrelin (Xue et al., 2020). There is very limited information of Gqmediated inhibition of Kv channels other than Kv7 and A-type channels, though inhibition by
Ca2+-calmodulin or PIP2 depletion were proposed mechanisms (Brown, 2018).

GIRK channels
G protein-activated inwardly rectifying potassium channels (GIRK, also known as Kir3) belong
to a family of seven G protein-gated, PIP2-sensitive potassium channels (Luscher & Slesinger,
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2010). The outward current through GIRK channels is enough to strongly hyperpolarize the
neurons and decreases excitability (Luscher & Slesinger, 2010). SNc DA neurons express the
GIRK2a and GIRK2c isoforms which form homomeric channels (Inanobe et al., 1999), whereas
VTA DA neurons express GIRK2c and GIRK3 (Cruz et al., 2004). GIRK channels are activated by
stimulation of Gi/o-coupled GPCRs, whose G subunit directly gates the channel by
strengthening the interaction between the channel and PIP2 (Luscher & Slesinger, 2010). The
most studied Gi-coupled GPCRs in midbrain DA neurons are the GABAB receptor and the D2
receptor; the latter acts as an autoreceptor (Ford, 2014). In addition to axonal release, DA
neurons mediate Ca2+-dependent release of DA from the somatodendritic compartment
(Beckstead et al., 2004; Rice & Patel, 2015). The somatodendritic release of DA activates D2
receptors on the neuron itself and on neighboring neurons, hyperpolarizing the DA neurons
and causing a cessation of activity (Beckstead et al., 2004; Dragicevic et al., 2014; Philippart &
Khaliq, 2018). The extracellular level of DA in the midbrain, as well as the basal activity of GIRK
channels, contribute to regulation of membrane potential and firing rates of DA neurons
(Luscher & Slesinger, 2010; Ford, 2014). While GIRK conductance is the major component of
D2 autoreceptor-mediated outward current (Beckstead et al., 2004), D2 autoreceptors also
decrease excitability by modulating Kv1 (Fulton et al., 2011), HCN (Gambardella et al., 2012),
and NALCN (Philippart & Khaliq, 2018).

In contrast to Gi/o-mediated activation of GIRK channels, Gq signaling was proposed to be a
universal inhibitor of GIRK channels in midbrain DA neurons as well as other cell types. Early
studies using heterologous expression systems implicated the G subunit, PLC, intracellular
Ca2+, and PKC in Gq-mediated inhibition of GIRK current, although the results were conflicting
across studies (Hill & Peralta, 2001; Lei et al., 2001; Mao et al., 2004). So far, the mechanisms
responsible for Gq-mediated inhibition of GIRK channels in midbrain DA neurons are equally
puzzling. Substance P suppressed GABAB-mediated outward current through activation of the
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neurokinin-3 (NK3) receptor, which is Gq-coupled; this effect was shown to be dependent on
PLC, intracellular Ca2+, and PKC (Xia et al., 2010). Intriguingly, a newer study demonstrated
that intracellular Ca2+ can directly and transiently inhibit D2- and GABAB-mediated GIRK
current on a 1-second time scale. While the rise in free Ca2+ could be induced by either
activation of group I mGluRs or direct store release, the inhibition of GIRK was not dependent
on PLC, PKC, PLA2, or calmodulin (Kramer & Williams, 2016). Finally, inhibition of GIRK by Gqcoupled mAChRs has been observed in other systems (Hill & Peralta, 2001), but it is unknown
whether this pathway occurs in midbrain DA neurons.

Sodium leak channel (NALCN)
As pacemaker cells, midbrain DA neurons have a considerably more depolarized membrane
potential compared to neurons that are quiescent at rest. When the pacemaker activity is
silenced by TTX treatment, a “resting membrane potential” around −56 mV is revealed (Khaliq
& Bean, 2010). Such value is much more depolarized than the equilibrium potential of
potassium (EK ~−90 mV), suggesting the existence of other resting conductances that are TTXresistant. A “leak” non-selective cationic channel, the sodium leak channel (NALCN), was
found to be crucial in pacemaking activity including that of midbrain DA neurons (Ren, 2011).
NALCN is structurally related to the Nav and Cav channels but is believed to be voltageinsensitive and non-inactivating (Ren, 2011). However, a recent study using heterologous
expression systems revealed voltage-dependent gating and selectivity for monovalent over
divalent cations (Chua et al., 2020). Inhibition of leak sodium current in VTA DA neurons
resulted in an average hyperpolarization of 11 mV (Khaliq & Bean, 2010). This implied that
NALCN provides a persistent Na+ current in VTA DA neurons that brings the membrane
potential close to AP threshold, permitting pacemaking. In contrast, NALCN currents are
smaller in SNc DA neurons, whose pacemaking is driven mainly by subthreshold Ca 2+
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oscillations. In addition to being TTX-resistant, NALCN is insensitive to Cs+ (permeable), TEA
(10 mM, impermeable), and Cav channel blockers such as nifedipine (Philippart & Khaliq, 2018;
Chua et al., 2020; Kschonsak et al., 2020).

Besides being a background conductance, NALCN activity is modulated by GPCRs. NALCN
forms a channel complex with UNC79, UNC80, and FAM155A, which are auxiliary subunits
necessary for its functional expression (Lu et al., 2009; Chua et al., 2020; Kschonsak et al.,
2020). UNC80 is required for GPCR regulation of NALCN by acting as a scaffold protein for Src
family kinases (SFKs) (Ren, 2011). Two neuropeptides – neurotensin and substance P –
increased DA neuron excitability by evoking a slow NALCN-mediated cation current (Lu et al.,
2009). Although both are coupled to Gq-related pathways, the neurotensin receptor 1/2 and
the substance P receptor activate NALCN via an SFK-dependent, G protein-independent
pathway (Lu et al., 2009). Conversely, NALCN is inhibited by 2 mM of extracellular Ca2+ and Gicoupled GPCRs in SNc DA neurons (Philippart & Khaliq, 2018). It has been suggested that the
action of Ca2+ is exerted through activation of the calcium sensing receptor (CaSR), a Gqcoupled GPCR that inhibits NALCN (Ren, 2011). The CaSR-NALCN coupling allows direct
transduction of extracellular Ca2+ concentrations to neuronal excitability, though whether this
is the mechanism in DA neurons has not been tested. The Gi-coupled D2 autoreceptors and
GABAB receptors inhibited NALCN and decreased pacemaking frequency via a G proteindependent mechanism (Philippart & Khaliq, 2018). This Gi-mediated pathway provides
another mechanism, in addition to activation of GIRK channels, how D2 and GABAB receptors
potently suppress DA neuron activity. These studies demonstrated NALCN as an important
regulator of DA neuron excitability in both spontaneous activity and integration of synaptic
inputs.
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TRPC channels as effectors of GPCR signaling

Biophysical properties of TRPC channels
Transient receptor potential (TRP) channels were discovered and named in 1975 after a
Drosophila mutant whose retinal photoreceptor cells only exhibited transient depolarization
to bright light instead of the sustained response in the wild type (WT) (Minke, 2010). Based
on sequence homology, 28 mammalian TRP channels were subsequently cloned and grouped
into 6 subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin),
TRPML (mucolipin), and TRPP (polycystin) (Nilius & Owsianik, 2011; Zheng, 2013). TRP
channels are nested within the voltage-gated ion channel superfamily and possess many
properties reminiscent of voltage-gated potassium channels (Yu & Catterall, 2004). TRP
subunits assemble into either homo- or heterotetrameric channels (Zheng, 2013; Cao, 2020).
Each subunit has 6 transmembrane α-helices (Yu & Catterall, 2004; Nilius & Owsianik, 2011;
Chen et al., 2020), with the S1-S4 helices forming the voltage sensor-like domain (VSLD) (Cao,
2020). In general, the voltage sensitivity of TRP channels is very low, making them
unresponsive to voltage in the physiological range (Yu & Catterall, 2004; Zheng, 2013). The
lack of voltage sensitivity is attributed to the loss of positively charged residues on the S4 helix
(Yu & Catterall, 2004; Zheng, 2013; Cao, 2020). The S5 and S6 helices form the pore domain,
which contains the ion conduction pathway and the selectivity filter (Zheng, 2013; Cao, 2020).
Perplexingly, the selectivity filters of most TRP channels lack conserved sequence or structural
characteristics that explain their ion selectivity (Cao, 2020). The cytosolic N- and C-termini
form large intracellular domains which serve as interaction sites for many factors and proteins
that regulate their expression and function (Nilius & Owsianik, 2011; Cao, 2020).

The TRPC subfamily contains 7 members that can be separated into four subgroups based on
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their sequence and functional similarity: TRPC1, TRPC2, TRPC4/5, and TRPC3/6/7 (Clapham et
al., 2001; Chen et al., 2020). TRPC2 is a pseudogene in humans and is mostly restricted to the
vomeronasal organ and sperm cells in rodents (Clapham et al., 2001; Nilius & Owsianik, 2011).
TRPC3/6/7 are highly similar, sharing ~75% of sequence identities (Clapham et al., 2001).
TRPC4 and TRPC1 are 65% and 45% identical to TRPC5, respectively (Zholos, 2014). When
forming heteromeric channels, TRPC subunits appear to preferentially assemble with
members of the same subgroup. Systemic studies using rat brain synaptosomes and various
heterologous expression systems found that TRPC2 does not interact with any other TRPC
subunit; TRPC1/4/5 co-assemble, and TRPC3/6/7 co-assemble, but cross-interactions
between the two subgroups do not occur (Goel et al., 2002; Hofmann et al., 2002). The results
were corroborated by functional experiments showing that a dominant-negative TRPC6
subunit suppressed TRPC3- and TRPC6-mediated current but not TRPC4- or TRPC5-mediated
current in HEK293 cells (Hofmann et al., 2002). The preferential intra-subgroup assembly is
not a hard-set rule, however. TRPC1 has been shown to form heteromeric channels with
TRPC3 and TRPC7 in heterologous expression systems, astrocytes, and human salivary gland
epithelial cells (Lintschinger et al., 2000; Liu et al., 2005; Zagranichnaya et al., 2005; Belkacemi
et al., 2017). Inter-subgroup heteromers of three different subunits (i.e., containing TRPC1,
TRPC4/5, and TRPC3/6/7) may exist in heterologous expression systems and embryonic brains
but not adult brains (Strubing et al., 2003; Storch et al., 2012). The assembly of TRPC4/5 with
TRPC3/6 requires the presence of TRPC1 (Strubing et al., 2003). Associations of TRPC3 with
TRPC4 in vascular endothelial cells (Poteser et al., 2006) and TRPC4 with TRPC6 in HEK293
cells (Yuan et al., 2007) were also reported. Therefore, the subunit composition of TRPC
channels varies widely across systems, though there appears to be preferential association
between members of the same subgroup.

Understanding the electrophysiological properties of TRP channels is difficult and complex.
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Besides their non-selective ionic conductance, the permeabilities and I-V relationships of
TRPC channels can be vary incredibly with different systems and subunit compositions.
Nonetheless, some patterns can still be found. TRPC channels conduct a non-selective cation
current. The permeability ratios of Na+, K+, and Cs+ of most TRP channels including TRPC are
approximately 1:1:1 (Inoue et al., 2001; McKemy et al., 2002; Feng, 2017). TRPC channels are
also highly permeable to divalent ions including Ca2+. The Ca2+/Na+ permeability ratios (PCa/PNa)
range from moderately Ca2+-biased (~10:1) to no selectivity (1:1) (Feng, 2017). Despite the
relatively high PCa/PNa, Ca2+ current is very small compared to monovalent cationic current,
even in solutions where Ca2+ is the only permeant cation (Strubing et al., 2001; Estacion et al.,
2006). Due to their non-selective nature, TRPC channels typically have a reversal potential
around 0 mV with physiological ion concentrations (Freichel et al., 2014; Feng, 2017). Though
considered to be mostly voltage-insensitive, TRPC channels do exhibit variable rectifications
in their I-V relationships. In general, TRPC1, TRPC3 and TRPC7 channels show roughly linear IV relationships (Zitt et al., 1996; Lintschinger et al., 2000; Liu et al., 2005; Poteser et al., 2006;
Sun et al., 2017), TRPC4, TRPC5, and TRPC6 channels exhibit the distinct “N-shaped” doubly
rectifying I-V relationships (Schaefer et al., 2000; Jung et al., 2003; Obukhov & Nowycky, 2005;
Storch et al., 2012; Kim et al., 2014), whereas it is common for heteromeric channels to be
outwardly rectifying (Strubing et al., 2001, 2003; Storch et al., 2012; Kim et al., 2014).

Mechanisms of TRPC channel activation by Gq signaling
Activation of TRPC channels by Gq-coupled GPCRs is well-documented in both neuronal and
non-neuronal cells. The literature consensus is that all TRPC subunits are activated
downstream of PLC and are intricately involved in Ca2+ signaling (Clapham et al., 2001; Chen
et al., 2020; Wang et al., 2020). However, just like the biophysical properties of TRPC channels,
elucidating the precise mechanisms of activation has been a complex and difficult subject. To
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understand the historical classification of TRPC subtypes based on mechanisms of activation,
a brief discussion of the experimental methods for measuring TRP channel activity is
unavoidable. One major mechanism, termed store-operated calcium entry (SOCE), refers to
the Ca2+ influx upon ER store depletion. The classic protocol for measuring SOCE consists of
pretreating cells with a SERCA inhibitor such as thapsigargin or cyclopiazonic acid (CPA) in the
absence of extracellular Ca2+ in order to deplete the ER store (Bird et al., 2008). Upon readdition of extracellular Ca2+, non-selective cation entry through TRPC channels can be
quantified by fluorescence Ca2+ imaging or patch-clamp technique (Schaefer et al., 2000; He
et al., 2005; Bird et al., 2008). Since SOCE can occur without stimulating plasma membrane
receptors, receptor-operated calcium entry (ROCE) is the counterpart mechanism that relies
on G protein signaling. The most commonly used agonist to evoke Gq signaling is carbachol
which targets the muscarinic receptors. Agonists of the histamine H1 receptor (i.e., histamine)
and P2Y receptors (i.e., ATP) are also used (Schaefer et al., 2000). Additional ways to stimulate
components of the Gq pathway include GTPγS infusion and the membrane-permeable DAG
analogue OAG (Schaefer et al., 2000; Jung et al., 2003; Storch et al., 2012). Although SOCE and
ROCE are independent mechanisms that can be dissected using experimental manipulations,
it should be noted that both processes occur upon activation of Gq-coupled GPCRs.

Since the proposal that TRPC channels constitute a major component of SOCE, TRPC1 and
other TRPC members have been intensely studied as store-operated channels (Chen et al.,
2020; Wang et al., 2020). SOCE was first described by Putney in 1986 as a ubiquitous cellular
mechanism to restore Ca2+ homeostasis (Putney, 1986). The physiological triggers for SOCE
include activation of Gq-coupled GPCRs, which generate inositol 1,4,5-triphosphate (IP3) and
DAG from PIP2 via PLC activity. IP3 then acts on the cognate IP3 receptor to release free Ca2+
from the ER. This store depletion activates the ER Ca2+-sensing protein stromal interaction
molecule (STIM1 and STIM2), which directly interacts with the plasma membrane Ca2+-
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selective ion channel Orai (Orai1, Orai2, Orai3) to induce Ca2+ entry and replenish the ER store
(Nesin & Tsiokas, 2014; Majewski & Kuznicki, 2015; Ambudkar et al., 2017). SOCE was first
described in mast and T cells (Nesin & Tsiokas, 2014; Ambudkar et al., 2017). The inward
current associated with SOCE in the immune cells has low conductance, is highly Ca2+-selective,
and was discovered to be Orai1-mediated (Ambudkar et al., 2017). However, TRPC channels
contribute to SOCE in a variety of other cell types, including neurons, skeletal muscles, smooth
muscles, epithelial secretory cells, and endothelial cells (Majewski & Kuznicki, 2015;
Ambudkar et al., 2017). TRPC1 physically interacts with both STIM1 and Orai1, which are
necessary for its activation, though the exact mechanism remains controversial (Nesin &
Tsiokas, 2014; Ambudkar et al., 2017). The current evidence supports a model in which TRPC1
is stored in intracellular vesicles in resting conditions. Upon store depletion, Ca 2+ entry
through Orai1 recruits TRPC1 to the plasma membrane where it is gated by STIM1 via
electrostatic interactions (Cheng et al., 2011). TRPC1-STIM1 and Orai1-STIM1 are located in
close proximity but form distinct channel complexes (Cheng et al., 2011). STIM1 also mediates
the assembly of TRPC1 with other TRPC subunits to form store-operated channels of various
properties (Yuan et al., 2007). As the result, SOCE current recorded in TRPC1-expressing cells
is a combination of TRPC1- and Orai1-mediated current, which has higher conductance and is
non-selective cationic. Therefore, SOCE in neurons may regulate excitability by mediating
postsynaptic current and initiating Ca2+-dependent signaling pathways (Hartmann et al., 2014;
Dou et al., 2018).

Receptor-operated activation of TRPC channels involves complex membrane lipid signaling.
Both the substrate and the products of PLC contribute to ROCE. PI(4,5)P2 (simplified as PIP2
unless otherwise specified) exerts dual effects, which explain why early studies obtained
paradoxical results. On one hand, direct application of PIP2 to the cytoplasmic side of insideout patches enhanced the opening of TRPC3, 5, 6, and 7 (Lemonnier et al., 2008; Trebak et al.,
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2009). On the other hand, intracellular infusion of PIP2 in whole-cell recording mode inhibited
TRPC4 and TRPC5 (Otsuguro et al., 2008; Trebak et al., 2009). Those results suggested that
multiple PIP2 binding sites are likely. PIP2 may act as a direct ligand or serve as a necessary cofactor that support channel function. At the same time, PIP2 bound at a different site may
exert tonic inhibition on the channel. Indeed, it was shown that PIP2 inhibition of TRPC4
depends on linkage of the C-terminal calmodulin/IP3-receptor-binding (CIRB) domain to actin
cytoskeleton via the scaffold protein Na+/H+ exchanger regulatory factor (NHERF) (Otsuguro
et al., 2008). This cytoskeletal complex likely stabilizes TRPC4 in the inactive conformation.
Depletion of PIP2 is necessary to relieve the channel from inactivation, but is not sufficient for
full activation without other components of the PLC pathway (Otsuguro et al., 2008). This
model also explains the results from the inside-out patches, where the inhibitory NHERFcytoskeleton complex is lost and thus the activating effects of PIP2 predominates. Consistently,
a newer study using FRET to measure PIP2 and DAG dynamics concurrently with TRPC6/7
current showed that both channel activation and inactivation were correlated with PIP2
reduction, while only channel activation was correlated with DAG production (Itsuki et al.,
2014). Importantly, the other phosphoinositides including PI(3,4)P2, PI(3,5)P2, PI(3,4,5)P3 and
IP6 had little or no effects on TRPC4 and TRPC5 (Otsuguro et al., 2008; Trebak et al., 2009),
indicating specific recognition of PIP2 by the channel protein rather than non-specific
electrostatic interactions with the charged lipids.

Activation of TRPC channels by DAG, one major product of PLC activity, is considered the
primary mechanism underlying ROCE (Chen et al., 2020; Wang et al., 2020). Despite DAG
acting as the agonist in this classical ligand-gated process, the exact DAG binding site remained
elusive. Only recently, a study of TRPC5 cryo-EM structure identified a putative DAG binding
pocket near the pore loop (Song et al., 2021). The DAG in this pocket is displaced by
pharmacological inhibitors, suggesting this site is responsible for the direct channel activation.
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However, OAG-induced current does not fully recapitulate the magnitude and kinetics of
receptor-stimulated current (Albert & Large, 2003), suggesting there are additional
mechanisms. Whether all TRPC members are activated by DAG has also been a controversial
topic. The traditional view is that the TRPC1/4/5 subgroup are activated by ER store depletion,
while TRPC3/6/7 are activated by receptor stimulation. This concept was consolidated by a
series of studies in the 1990s through the early 2000s showing TRPC1, 3, 4, and 5 were
activated by thapsigargin treatment, but TRPC6 and 7 were not (Wang et al., 2020).
Meanwhile, the TRPC3/6/7 subgroup was found to be directly activated by DAGs, which did
not appear to activate TRPC4/5 (Wang et al., 2020). The concept was contested by a number
of studies showing that TRPC3/7-containing channels are sensitive to both DAGs and store
depletion (Kiselyov et al., 1998; Zagranichnaya et al., 2005), while some TRPC4/5-containing
channels are activated by Gq-coupled GPCRs but not store depletion (Schaefer et al., 2000;
Strubing et al., 2001). A recent study discovered that co-expression with Gq-coupled GPCRs
and depletion of PIP2 confer DAG sensitivity to TRPC4/5 by causing dissociation of NHERF1/2
from the channel protein (Storch et al., 2017). These results not only explained why
application of DAGs alone fails to induce TRPC4/5 current, but also highlighted NHERF as a
dynamic regulator of lipid gating by both DAG and PIP2. Thus, DAG sensitivity appears to be a
common feature of all TRPC subunits. The distinction between “store-operated” and
“receptor-operated” channels is functional but not genetic. While all TRPC subunits are
capable of forming store-operated or receptor-operated channels, studies suggested a model
in which a single cell maintains separate pools of TRPC channels coupled to the SOCE and
ROCE pathways (Vazquez et al., 2003; Zagranichnaya et al., 2005). SOCE and ROCE channels
exhibit different properties and are independently regulated, although both pools would be
activated by the physiological receptor agonists.

A dynamic mechanism involving the IP3 receptor and calmodulin, as well as Ca2+ itself,
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constitute other components of the PLC pathway that regulate TRPC channel activation.
TRPC5 is the only TRPC member that is constitutively active (Schaefer et al., 2000; Jeon et al.,
2012) and directly activated by Ca2+ [EC50 = 635 nM at membrane potential (Vm) = −80 mV;
(Gross et al., 2009)]. Upon store depletion or receptor stimulation, TRPC channels can be
directly activated by the IP3-bound IP3 receptor. As previously discussed, all TRPC subtypes
possess a C-terminal CIRB domain where calmodulin and IP3 receptor share a mutually
exclusive binding site (Tang et al., 2001). Calmodulin binds to the CIRB domain constitutively
and suppresses the basal activity of the channel (Zhang et al., 2001). This calmodulin-TRPC
interaction partially accounts for the inhibitory effects of Ca2+ on all TRPC subtypes (Wang et
al., 2020). The binding of calmodulin to TRPC is Ca2+-dependent; the affinity differs for each
TRPC subtype (Kd ranging from 10 nM for mTRPC2 to 290 nM for mTRPC6), suggesting their
sensitivity to Ca2+-mediated inhibition varies (Tang et al., 2001). Interestingly, an active IP3
receptor competes for the CIRB domain and displaces calmodulin, relieving the channel from
inhibition (Zhang et al., 2001). All three mammalian IP3 receptors can bind to the CIRB domain
via a conserved C-terminal domain (Tang et al., 2001). IP3 alone does not affect TRPC channels
and its actions is dependent on IP3 receptors. Direct application of IP3 to inside-out patches
had no effects on TRPC3/6/7 channel opening (Lemonnier et al., 2008), while another study
showed that the activating effect of IP3 requires the presence of active IP3 receptors (Kiselyov
et al., 1998). Therefore, direct channel activation by IP3 receptors is another PLC-mediated
mechanism that may explain why DAG alone does not recapitulate all features of TRPC
activation (Albert & Large, 2003).

TRPC channels in midbrain dopaminergic neurons
All TRPC subtypes except TRPC2 are expressed in the substantia nigra (Chung et al., 2007; Zeng
et al., 2016). Interestingly, there appear to be mismatches between the levels of TRPC mRNAs
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and proteins in the SN: the levels of TRPC3 and TRPC6 mRNAs were the highest, whereas
immunoreactivities for TRPC3, TRPC4, and TRPC7 were the most intense (Sylvester et al., 2001;
Chung et al., 2007). The caveat was that these early studies did not distinguish SNc from SNr,
nor did they identify the cell types involved. The first definite and detailed reports of TRPC
protein expression in adult rat SNc DA neurons were done by Fusco and coworkers. Their
immunohistochemical studies showed that TRPC1, TRPC5, and TRPC6 are expressed in SNc DA
neurons (De March et al., 2006; Martorana et al., 2006; Giampa et al., 2007). Importantly,
TRPC1 and TRPC6 showed intense staining in the somatodendritic compartments and colocalization with mGluR1 (Martorana et al., 2006; Giampa et al., 2007). TRPC1 was
preferentially localized in the distal dendrites and absent in the glia (Martorana et al., 2006).
In contrast, TRPC5 was found localized in the neuronal nuclei and did not co-localize with
TRPC1 or mGluR1 (De March et al., 2006). Finally, and intriguingly, TRPC3 showed preferential
localization in oligodendrocytes in the SN, compared to the very light staining in a subset of
DA neurons and little to no staining in astrocytes and microglia (Fusco et al., 2004). Single-cell
RT-PCR analysis performed by the Mercuri Lab found that the majority of SNc DA neurons
express mRNAs for TRPC1 and TRPC5, a significant minority express TRPC4 and TRPC6, and
very few cells express TRPC3 (Tozzi et al., 2003). Their results were consistent with those of
the Fusco Lab that TRPC1, TRPC5, and TRPC6 are the most abundant subtypes in SNc DA
neurons, although TRPC7 was not examined by either lab group.

Activation of TRPC channels by mGluR1 in DA neurons was first demonstrated by Mercuri and
coworkers. In their two studies using acute rat SNc slices, they found that mGluR1 agonism
elicited an approximately linear, non-selective cationic current with a reversal potential
around 0 mV (Tozzi et al., 2003; Cucchiaroni et al., 2010). The current correlated with
membrane potential depolarization and an increase in spontaneous firing frequency
(Cucchiaroni et al., 2010). Pharmacological characterization showed that this mGluR1-induced
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current was sensitive to non-selective TRP channel blockers such as SKF96365, 2-APB, and
flufenamic acid but insensitive to manipulations of intracellular Ca2+ release such as
thapsigargin, CPA, dantrolene, and BAPTA (Tozzi et al., 2003). Those characteristics suggested
that mGluR1s are coupled to TRPC channels via the ROCE pathway and are independent of
SOCE. While there are currently no equivalent studies on VTA DA neurons, mGluR1- and M5
receptor-induced inward current and Ca2+ release have been reported in this brain region
(Foster et al., 2014), suggesting Gq-TRPC signaling likely also occurs in VTA DA neurons.

The participation of TRPC channels in SOCE has been documented in mouse SNc DA neurons
by the lab group of Singh (Selvaraj et al., 2012; Sun et al., 2017). The pacemaking activity of
SNc DA neurons is critically dependent on L-type calcium channels. It has been proposed that
the increased Ca2+ load underlies the vulnerability of SNc DA neurons to degeneration
compared to VTA DA neurons (Dragicevic et al., 2015). The Singh Lab showed that, as opposed
to generating an excitatory response, TRPC1 activation actually decreases excitability in SNc
DA neurons via inhibition of L-type calcium current (Sun et al., 2017), as previously reported
in other systems. Thapsigargin-induced Ca2+ store depletion elicited a linear current with a
reversal potential around 0 mV; this current was absent in TRPC1 KO mice (Selvaraj et al., 2012;
Sun et al., 2017). Thapsigargin also increased the physical interaction between Cav1.3 and the
TRPC1-STIM1 complex, decreased the maximal conductance of Cav1.3, and reduced the
spontaneous firing frequency of SNc DA neurons (Sun et al., 2017). Consistent with the animal
studies, postmortem brain tissues from Parkinson’s disease patients showed downregulation
of TRPC1 and upregulation of Cav1.3 (Sun et al., 2017). Overall, studies by the Singh Lab
suggest that the antagonistic relationship between TRPC1 and Cav1.3 may underlie the
selective vulnerability of SNc DA neurons.

So far, the physiological significance of TRPC channels in VTA DA neurons is largely unclear.

49
Nonetheless, one study implicated TRPC4 in the regulation of VTA DA neuron firing, sociability,
and drug reward. TRPC4 mRNA and protein were found expressed in SN and a uniformlydistributed subset (~37%) of VTA DA neurons (Klipec et al., 2016). This suggests that TRPC4
modulation may be circuit-specific and targets a subpopulation of DA neurons. In acute brain
slices prepared from the TRPC4 KO rats, VTA DA neurons had significantly lower spontaneous
firing rates (Klipec et al., 2016). Behaviorally, the TRPC4 KO rats were less socially exploratory
compared to WT counterparts, perhaps due to increased anxiety as proposed in previous
studies. Importantly, the TRPC4 KO rats showed reduced cocaine self-administration, but did
not differ in multiple learning tasks and sucrose self-administration compared to WT (Klipec
et al., 2016). Since this study utilized global TRPC4 KO, it was not known whether intrinsic
processes in DA neurons or synaptic inputs were responsible for the phenotypes.
Nevertheless, the findings that TRPC4 selectively modulates sociability and drug reward
suggest that TRPC4 modulators may provide treatments for a variety of DA-related disorders.
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SPECIFIC AIMS
Midbrain dopamine (DA) neurons in the ventral tegmental area (VTA) plays a crucial role in
reward and motivational behaviors including addiction. Upon rewarding or conditioned
stimuli, DA neurons are directly excited by cholinergic inputs from the pedunculopontine
tegmental (PPT) and laterodorsal tegmental (LDT) nuclei. Activation of the Gq-coupled M5
muscarinic receptor (mAChR), the predominant subtype expressed in midbrain DA neurons,
increases firing frequency and striatal DA release. Blockage of mAChRs in the VTA has shown
promising results in preclinical models of drug addiction to attenuate acute reward and drugconditioned behaviors.

Our working hypothesis is: “mAChRs activate a non-selective cationic conductance and/or
inhibits a K+ conductance resulting in an increase in electrical excitability of VTA DA neurons.”

Aim 1: Investigating the modulation of action potential (AP) frequency, regularity, and
kinetics by muscarinic agonism in VTA DA neuron.
1.1: Determining whether mAChR activation alters firing pattern. Inhibition of SK channels
increases AP irregularity and facilitates burst firing in VTA DA neurons. To determine whether
mAChRs modulate AP timing, acute brain slices will be prepared from WT C57BL/6 mice. Cellattached and whole-cell voltage- and current-clamp will be used to record spontaneous firing
of VTA DA neurons. The frequency and regularity of APs will be compared upon muscarinic
activation by bath application of the agonist carbachol and inhibition by the antagonist
atropine.
1.2: Determining whether mAChR activation alters the kinetics of AP shape. Changes in ion
channel activities that regulate AP shape may underlie increases in firing frequency. However,
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AP shape also varies with membrane potential and the availability of voltage-gated channels.
To determine whether mAChRs modulate the kinetics of AP shape irrespective of membrane
potential, the AP shape recorded during carbachol treatment in Sub-Aim 1.1 will be analyzed
when the membrane potential changes are compensated by the clamping circuit.

Aim 2: Investigating the contribution of intrinsic membrane properties and extrinsic inputs
in muscarinic excitation of VTA DA neurons.
2.1: Determining the modulation of intrinsic membrane properties by muscarinic agonism.
To determine whether mAChRs modulate HCN and K+ conductances in VTA DA neurons,
intrinsic firing properties including sag ratio, spike frequency adaptation, and frequencycurrent relationship will be assessed using a current step protocol during carbachol bath
treatment. In addition, the carbachol-induced changes in membrane potential and input
resistance will be quantified using whole-cell current-clamp when spontaneous firing is
inhibited by tetrodotoxin (TTX).
2.2: Determining whether mAChR activation alters sIPSCs in VTA DA neurons. VTA DA
neurons are tonically inhibited by GABAergic neurons in the local circuit. To determine
whether muscarinic inputs modulate VTA DA neuron activity via activation of mAChRs located
on the GABAergic interneurons, sIPSCs will be recorded in VTA DA neurons with bath
application of carbachol.

Aim 3: Characterizing the pharmacological sensitivity of mAChR-induced currents in VTA DA
neurons.
3.1: Determining whether the mAChR-induced current is sensitive to non-selective ion
channel blockers. To determine the ionic composition of mAChR-induced currents in VTA DA
neurons, whole-cell voltage-clamp experiments will be performed with bath application of
carbachol co-treated with the non-selective K+ and Ca2+ channel blockers TEA, Cs+, and Cd2+.
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3.2: Determining whether the mAChR-induced current is sensitive to a TRPC channel blocker.
In central neurons, TRPC are non-selective cationic channels commonly modulated by Gq
signaling. To determine whether activation of TRPC channels participates in mAChR-induced
currents in VTA DA neurons, carbachol-induced whole-cell currents will be recorded with bath
application of the TRPC-selective blocker BTP2.
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METHODS
Acute slice preparation and identification of cells
C57BL/6 mice of either sex, postnatal day 13-31 (median age = 18) were anesthetized with
isoflurane and quickly decapitated. Horizontal 200-μm midbrain slices were prepared in icecold ACSF solution containing (in mM): 125 NaCl, 25 NaHCO3, 3 KCl, 1.2 CaCl2, 1.2 MgSO4, 1.25
NaH2PO4, 10 glucose, 0.4 ascorbic acid, saturated with 95% O2 and 5% CO2. Slice were
incubated at 32 °C in the same ACSF solution for at least 30 min. before patch-clamp
recordings. For all patch-clamp recordings, slices were transferred to a chamber with
continuous perfusion of ACSF at 34 °C. Borosilicate glass patch electrodes with a tip resistance
of 3-6 MΩ were filled with intracellular solutions (see detailed methods of each experiment).
Recordings were made using an A-M Systems 2400 amplifier and Strathclyde
Electrophysiology Software (WinWCP & WinEDR, University of Strathclyde). On the horizontal
brain slice, VTA was identified by anatomical location using substantia nigra pars compacta
(SNc) and medial terminal nucleus of the accessory optic tract (MT) as the landmarks, as VTA
is rostral to the MT and medial to both SNc and MT (Masi et al., 2015; Krashia et al., 2017).
VTA dopaminergic (DA) neurons were identified by cell morphology with a large, fusiform or
multipolar soma (Grace & Onn, 1989). Whenever possible, the identity was further confirmed
by electrophysiological characteristics measured using a current step protocol (see
Experiment 2). The majority of neurons recorded in this study were located in the lateral VTA.
These neurons exhibit “conventional” electrophysiological characteristic including broad
action potential width, slow spontaneous firing rates (<10 Hz), a prominent HCN sag, delayed
evoked firing, and in addition, a hyperpolarizing response to dopamine (60 M) that was
applied by the end of the trials (Grace & Onn, 1989; Lammel et al., 2008; Roeper, 2013; Masi
et al., 2015; Krashia et al., 2017).
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Recording solutions and measurements of liquid junction potential
The intracellular solution for patch-clamp experiments contained (in mM): 122 K-gluconate, 7
NaCl, 0.58 MgCl2, 0.03 CaCl2, 0.1 EGTA-K, 10 HEPES, 14 phosphocreatine, 4 ATP-Mg, 0.3 GTPNa, pH 7.3 adjusted with KOH, 290 mOsm/L; this solution was used for all experiments except
measurements of sIPSCs (Experiment 3). The online program Maxchelator was used to
calculate the amounts of Ca2+, EGTA, and Mg2+ added, resulting in final concentrations of 100
nM free Ca2+ and 1 mM free Mg2+. The Ca2+ and EGTA concentrations were calculated based
on the assumption that distilled water naturally contains ~5-7 M free Ca2+. The liquid
junction potential (LJP) was measured empirically by constructing a 1 M KCl-infused agar
bridge connected to the headstage. Switching from symmetrical intracellular solution to
extracellular ACSF yielded a LJP of −8.7 mV, which was used to correct the action potential
threshold potential and membrane potential data from Experiment 1 and 4. No LJP correction
was applied to the voltage reset of the current step protocol in Experiment 2 and the holding
voltage of voltage-clamp recordings in Experiment 3 and 5.

Drug application
All pharmacological reagents were perfused in bath. To stimulate or inhibit the mAChRs, the
non-selective cholinergic agonist carbachol (10 M) and the muscarinic antagonist atropine
(5 M) were used, respectively. For most experiments, one set of cells was first treated with
carbachol followed by atropine to reverse the carbachol-induced effects, while a second set
of cells was pretreated with atropine followed by simultaneous perfusion of atropine and
carbachol to block the muscarinic components of carbachol-induced effects. Each drug was
perfused for at least 4 min. to elicit the maximum response before measurements were taken.
Drugs were prepared and aliquoted as either water or DMSO stock depending on the solubility.
The final DMSO concentration in the ACSF was 0.05% (v/v).
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Experiment 1: mAChR modulation of tonic pacemaking activity, AP shape, and AP kinetics
Spontaneous APs of VTA DA neurons were recorded in either gap-free cell-attached or wholecell current-clamp configuration. Only cells that maintained stable firing were included. In the
cell-attached experiments, smaller pipette tips (5-9 MΩ) were used to prevent rupture of the
plasma membrane. After a tight seal (>1 GΩ) was formed, the cells were held at 0 mV in the
voltage-clamp mode to record AP currents. After each trial, the cell identity was confirmed by
a current step protocol and response to dopamine in the whole-cell configuration. In the
current-clamp experiments, larger pipette tips (3-6 MΩ) were used. After forming a tight seal,
the membrane was ruptured by gently applying negative pressure to achieve the whole-cell
configuration. The cell identity was confirmed by application of a current step protocol in the
beginning and response to dopamine after each trial. Spontaneous firing activity was recorded
with a sampling interval of 0.02 ms and low-pass filtered at 5 kHz. The AP events were
detected and analyzed using Mini Analysis, except the detection of afterhyperpolarization
(AHP) amplitude and duration was done by running scripts in OriginPro. Firing frequency was
calculated in Hz from the number of APs in a 1-min interval, while firing regularity was
measured as the mean coefficient of variation (CoV) of interspike intervals (ISI). AP shape data
were derived from the average AP threshold, amplitude, and half-width in the 1-min interval
when there was no current injection. AP threshold was defined as the inflection point voltage
at the onset of the sodium spike, amplitude the potential difference between the threshold
and the peak of the AP, and half-width the AP duration at the voltage halfway between the
threshold and the peak. To determine whether mAChR activation affects AP kinetics, the
average Vm after drug treatments was restituted to the baseline value by current injection.
The firing pattern and AP shape parameters were re-analyzed in this condition after the Vm
changes were compensated. In addition, an average AP waveform was generated from APs in
a 1-min interval for analysis of afterhyperpolarization (AHP) kinetics. AHP amplitude was
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calculated by subtracting the threshold potential from the AHP peak potential, while AHP
duration was the time between the AP threshold potential and the AHP peak. Only cells that
maintained stable access resistance (either <20% change or within ± 2 MΩ if the initial access
resistance was <10 MΩ) by the end of the trial were included in the data pool. In addition,
cells with outlier result values were excluded using Peirce’s criterion. Data were analyzed using
one-way repeated measures (RM) ANOVA with post-hoc Tukey’s test or the non-parametric
Friedman test with post-hoc Dunn’s test, depending on whether the distribution was normal.
All results are shown as mean ± SEM.

Experiment 2: mAChR modulation of intrinsic firing properties
A current step protocol was performed in the whole-cell configuration. The protocol consisted
of a series of 600-ms steps ranging from −200 pA to +200 pA, with a 25 pA increment between
each step. Before applying the step protocol, the DA neurons were clamped at −60 mV.
Intrinsic firing properties including HCN sag, frequency-current (f-I) relationship, and spike
frequency adaptation were compared before and after bath perfusion of mAChR drugs. The
HCN sag ratio was calculated by dividing the amplitude of steady-state potential by the
amplitude of the most negative hyperpolarizing potential during the −200 pA step (steadystate potential/lowest potential; each value is calculated from differences from −60 mV). Spike
frequency adaption ratio (FAR) was measured as the instantaneous firing frequency of the last
AP to that of the first AP during the +200 pA step (last AP/first AP). The instantaneous firing
frequency was defined as the reciprocal of the interval between two consecutive APs. Finally,
the f-I relationship was determined as the mean firing frequency during the +200 pA step,
since an f-I relationship plot across the entire range of current steps could not be constructed
due to the low firing frequency of DA neurons. OriginPro scripts were used to analyze the
intrinsic membrane properties. Data were analyzed using one-way RM ANOVA with post-hoc
Tukey’s test. All results are shown as mean ± SEM.
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Experiment 3: the effects of mAChR activation on sIPSCs in DA neurons
Spontaneous inhibitory post-synaptic currents (sIPSCs) were recorded using whole-cell
voltage-clamp from the DA neurons with the following intracellular solution (in mM): 120 Csmethanesulfonate, 8 NaCl, 10 HEPES, 10 Cs-BAPTA, 10 QX-314 chloride, 2 ATP-Mg, 0.1 GTPNa, pH 7.3 adjusted with CsOH. Since this intracellular solution prevented firing, HCNmediated voltage sag, and activation of D2 autoreceptor response, VTA DA neurons were
identified by anatomical location and cell morphology. No synaptic blockers were added to
the bath solution to minimize disruption of tonic synaptic activity. sIPSCs were recorded as
outward currents by holding the Vm at +15 mV, the reversal potential of ionotropic glutamate
receptors, in order to eliminate excitatory post-synaptic currents. Carbachol and atropine
were bath perfused for 5 min. before the measurements were taken. The average frequency
and amplitude of sIPSCs in a 3-min. interval during each treatment were analyzed using Mini
Analysis. Data were analyzed using one-way RM ANOVA with post-hoc Tukey’s test. All results
are shown as mean ± SEM.

Experiment 4: the effects of mAChR activation on membrane potential and input resistance
without spontaneous firing activity
TTX (500 nM) was added to the bath solution to eliminate spontaneous firing. Vm was
recorded in the gap-free whole-cell current-clamp mode before and after drug treatment. The
average value of Vm was obtained by plotting the Vm at 20-sec intervals as a histogram of 0.1
mV width and fitting to Gaussian distribution function in ClampFit. Every 22 sec, a small
current pulse, −15 to −40 pA in amplitude and 500 ms in duration, was injected to monitor
the input resistance. The amount of current injected varied for each cell to evoke a
hyperpolarization between 5 to 10 mV. Input resistance was calculated using Ohm’s Law by
dividing the peak hyperpolarization potential evoked during the step by the amount of current
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injected. Trials with >20% change in access resistance or more than ± 2 MΩ change if the initial
access resistance was <10 MΩ were discarded from input resistance analysis and only used
for report of membrane potential. Data were analyzed using one-way RM ANOVA with posthoc Tukey’s test or the non-parametric Friedman test with post-hoc Dunn’s test, depending
on whether the distribution was normal. All results are shown as mean ± SEM.

Experiment 5: characterization of the mAChR-induced inward current
In the whole-cell voltage-clamp configuration, carbachol was used as the agonist to induce an
inward current. Atropine was used as a negative control applied at the end of the trial; if the
current failed to return to baseline level with atropine, the cell is discarded. Cells that had
>20% change in the access resistance were also discarded. TTX (500 nM, stock in water) was
added throughout all recordings to prevent synaptic activities. TEA was applied by substituting
20 mM TEA (from TEA-Cl powder) for equimolar NaCl in the ACSF solution. The other blockers
Cs+ (10 mM, from CsCl powder), Cd2+ (200 M, CdCl2 stock in water), and BTP2 (5 M, stock
in DMSO) were added directly to fully oxygenated ACSF. After bath perfusion of carbachol or
the blockers, the peak response was observed before switching to the next treatment, which
usually took 200-300 sec. except for BTP2 which was perfused for 10 min before
measurements were taken. The voltage-clamp recordings were acquired at a sampling interval
of 0.1 ms with 2 kHz low-pass filter and were further digitally filtered using ClampFit at 1 kHz
before data analysis. The peak current amplitude and the standard deviation (SD) of current
fluctuations were calculated by plotting the current traces in a 10-sec interval as a frequency
histogram and fitting the histogram to Gaussian distribution in ClampFit. The peak carbachol
current amplitude and changes in carbachol-induced current fluctuations in the presence of
different blockers were compared using the Kruskal-Wallis test with post-hoc Dunn’s test,
except for the amplitudes of carbachol current before and after BTP2 treatment were
compared using paired t-test. The SD of current fluctuations from the same set of cells was
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analyzed using one-way RM ANOVA with post-hoc Tukey’s test or the non-parametric
Friedman test with post-hoc Dunn’s test, depending on whether the distribution was normal.
The current amplitude data are shown as mean ± SEM, whereas the current fluctuation data
are displayed as box and whisker plots.

Softwares used for graphing and statistical analysis
OriginPro was used to plot representative traces. The numerical data were graphed and
performed statistical analysis in GraphPad Prism.
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RESULTS
Activation of muscarinic receptors increases the firing rates of VTA dopamine
neurons without affecting firing pattern
Cell-attached patch-clamp experiments were performed on VTA DA neurons in acutely
prepared brain slices to determine the effects of muscarinic acetylcholine receptor (mAChR)
agonism on endogenous firing pattern (Figure 1A). DA neurons of the lateral VTA were
identified by relative location to the MT and SNc, large soma size, and electrophysiological
characteristics including slow spontaneous firing, broad AP width, large HCN-mediated
voltage sag evoked by a current step protocol, and hyperpolarizing response to DA (Grace &
Onn, 1989; Lammel et al., 2008; Roeper, 2013; Masi et al., 2015; Krashia et al., 2017). In the
cell-attached experiments, the cell identity was confirmed post-hoc by breaking in the cell
membrane and running the current step protocol in the whole-cell configuration. Consistent
with previous reports (Vandecasteele et al., 2011), VTA DA neurons are spontaneously active
with a baseline firing rate of 4.53 ± 0.34 Hz (n = 17). The pacemaking is highly regular,
quantified as a mean coefficient of variation of the interspike interval (CoV of ISI) of 0.064 ±
0.010. Bath application of carbachol (10 M), a non-selective cholinergic agonist, significantly
accelerated the firing frequency to 6.05 ± 0.37 Hz, corresponding to an average increase of
1.52 ± 0.18 Hz. After the carbachol treatment, carbachol was replaced by bath perfusion of
the mAChR antagonist atropine (5 M). Atropine reversed the firing frequency to 4.82 ± 0.34
Hz, which was not significantly different from the baseline value (Figure 1B; F2.0,32 = 41.47, p
< 0.0001****, n = 17, one-way RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p <
0.0001****, Base vs. Atro: p = 0.2794, Carb vs. Atro: p < 0.0001****). In contrast, firing
regularity was not affected by carbachol or atropine; the CoV of ISI did not show significant
changes (Figure 1C; Base = 0.064 ± 0.010, Carb = 0.053 ± 0.004, Atro = 0.057 ± 0.008; Fr =
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0.3529, p = 0.8382, n = 17, Friedman test).
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Figure 1. Activation of muscarinic receptors increases spontaneous firing frequency without
affecting firing regularity in cell-attached patch-clamp recordings. (A) Representative cellattached recording of VTA DA neuron activity in baseline, after muscarinic activation by bath
perfusion of the agonist carbachol (10 M), and muscarinic blockage by the antagonist
atropine (5 M). (B) Carbachol increased spontaneous firing frequency, an effect that was
reversed by atropine. (C) Carbachol and atropine had no effects on firing regularity, measured
as the coefficient of variation of the interspike interval (CoV of ISI). (**** p < 0.0001)
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The same experiment was performed using the whole-cell current-clamp technique to gain
access to measurements of action potential shape and membrane potential (Figure 2A). In
this configuration, bath application of carbachol increased the pacemaking frequency by 1.79
± 0.29 Hz, from the baseline value of 3.64 ± 0.23 to 5.43 ± 0.42 Hz. When atropine was
subsequently applied, the pacemaking frequency decreased to 4.25 ± 0.43 Hz, again not
significantly different from the baseline value (Figure 2B; F1.5,21 = 24.34, p < 0.0001****, n =
15, one-way RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p < 0.0001****, Base vs.
Atro: p = 0.1450, Carb vs. Atro: p < 0.0001****). There was a slight decrease in firing regularity
with carbachol treatment, as shown by the small increase in the CoV of ISI (Figure 2C; Base =
0.056 ± 0.005, Carb = 0.071 ± 0.004). However, this decrease in firing regularity was not
reversed by atropine; the value of CoV of ISI further increased by the time atropine was
perfused (Figure 2C; Atro = 0.081 ± 0.006; F1.8,25 = 9.867, p = 0.0010***, n = 15, one-way RM
ANOVA with post-hoc Tukey’s test, Base vs. Carb: p = 0.0230*, Base vs. Atro: p = 0.0050**,
Carb vs. Atro: p = 0.1933). This progressive increase in firing irregularity suggests a timedependent effect not specific to mAChR activation, probably resulting from a loss of
intracellular components during the long recordings in the whole-cell configuration.

To determine whether carbachol speeds up pacemaking via membrane potential
depolarization, we injected hyperpolarizing current to bring the average Vm to baseline levels
after carbachol and atropine treatments, shown in the set of cells in Figure 2B & C. When the
carbachol-induced changes in Vm were compensated, the pacemaking frequency was
restored to baseline value and no longer differed between any treatment (compare Figure 2B
vs. Figure 2D; Base = 3.64 ± 0.23 Hz, Carb = 3.63 ± 0.29 Hz, Atro = 3.48 ± 0.26 Hz; F1.8,25 =
0.7884, p = 0.4531, n = 15, one-way RM ANOVA). In contrast, during carbachol treatment there
was a slight decrease in AP regularity (compare Figure 2C vs. Figure 2E; Base = 0.056 ± 0.005,
Carb = 0.092 ± 0.007), which was not reversed by atropine, similar to the results when changes
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in Vm were not compensated (Atro = 0.079 ± 0.005; F1.7,24 = 11.93, p = 0.0004***, n = 15, oneway RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p = 0.0029**, Base vs. Atro: p =
0.0073**, Carb vs. Atro: p = 0.1995). This suggests that mAChR activation increases
pacemaking frequency mainly by depolarizing Vm and do not disrupt the ion channel
mechanisms essential for spike generation.

To confirm that the reversal of the firing frequency increase was due to mAChR antagonism,
a separate set of VTA DA neurons were pretreated with atropine for 5 min. before the cotreatment of atropine and carbachol. In this protocol, atropine completely prevented the
effect of carbachol on firing frequency (Figure 2F; Base = 4.86 ± 0.33 Hz, Atro = 5.21 ± 0.31 Hz,
Atro + Carb = 5.24 ± 0.33 Hz; F1.3,19 = 3.394, p = 0.0718, n = 16, one-way RM ANOVA). Atropine
and the following co-treatment with carbachol also had no effects on firing regularity (Figure
2G; CoV of ISI: Base = 0.059 ± 0.005, Atro = 0.066 ± 0.007, Atro + Carb = 0.078 ± 0.008; Fr =
6.125, p = 0.0468*, n = 16, Friedman test with post-hoc Dunn’s test, which reveals no
significant differences between treatments). Overall, the cell-attached and whole-cell
experiments produced the same results. Both techniques show that mAChR activation
increases pacemaking frequency without affecting firing regularity in VTA DA neurons in our
experimental conditions.
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Figure 2. Activation of muscarinic receptors increases spontaneous firing frequency without
affecting firing regularity in whole-cell current-clamp recordings. (A) Representative wholecell current-clamp recording of VTA DA neuron activity in baseline and after carbachol and
atropine application. (B) Carbachol increased spontaneous firing frequency, an effect that was
reversed by atropine. (C) Carbachol caused a small decrease in firing regularity that was not
reversed by atropine. (D) The effect of carbachol on firing frequency was eliminated when
membrane potential was compensated to baseline level via current injection. (E) In contrast,
alterations in firing regularity were not suppressed by resetting membrane potential. (F, G)
Atropine pretreatment blocked the effects of carbachol. Atropine alone did not affect firing
frequency and firing regularity. (* p < 0.05; ** p < 0.01; **** p < 0.0001)
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Activation of muscarinic receptors alters action potential shape
The carbachol-induced increase in firing frequency was accompanied by changes in action
potential (AP) shape (Figure 3A, left panel). To investigate the ionic conductances involved in
carbachol-induced excitation during spontaneous firing, we analyzed changes in the average
AP waveform. At baseline, VTA DA neurons have an AP threshold of −36.28 ± 0.62 mV, an AP
amplitude of 61.60 ± 1.06 mV, and an AP half-width of 1.28 ± 0.07 ms (n = 15). Bath perfusion
of carbachol significantly raised AP threshold to −33.39 ± 0.81 mV (Figure 3B), reduced AP
amplitude to 52.69 ± 1.47 mV, (Figure 3C), and broadened AP half-width to 1.45 ± 0.10 ms
(Figure 3D). The subsequent atropine treatment restored AP half-width to baseline value
(Figure 3D; Atro = 1.31 ± 0.08 ms; F1.7,24 = 24.05, p < 0.0001****, n = 15, one-way RM ANOVA
with post-hoc Tukey’s test, Base vs. Carb: p = 0.0001***, Base vs. Atro: p = 0.3780, Carb vs.
Atro: p = 0.0005***), but only partially reversed the carbachol-induced increase in in AP
threshold (Figure 3B; Atro = −34.65 ± 0.84 mV; F1.8,25 = 32.85, p < 0.0001****, n = 15, one-way
RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p < 0.0001****, Base vs. Atro: p =
0.0041**, Carb vs. Atro: p = 0.0035**) and reduction in AP amplitude (Figure 3C; Atro = 56.89
± 1.94 mV; F1.8,26 = 36.82, p < 0.0001****, n = 15, one-way RM ANOVA with post-hoc Tukey’s
test, Base vs. Carb: p < 0.0001****, Base vs. Atro: p = 0.0034**, Carb vs. Atro: p = 0.0012**).

In comparison, the set of cells pre-treated with atropine (Figure 3A, right panel) showed that
there were progressive increases in AP threshold (Figure 3J; Base = −37.58 ± 0.44 mV, Atro =
−37.01 ± 0.55 mV, Atro + Carb = −36.37 ± 0.69 mV; F1.2,19 = 7.346, p = 0.0103*, n = 16, one-way
RM ANOVA with post-hoc Tukey’s test, Base vs. Atro: p = 0.0230*, Base vs. Atro + Carb: p =
0.0266*, Atro vs. Atro + Carb: p = 0.1212) and reduction in AP amplitude (Figure 3K; Base =
56.44 ± 1.21 mV, Atro = 54.44 ± 1.19 mV, Atro + Carb = 52.06 ± 1.17 mV; F1.4,20 = 23.46, p <
0.0001****, n = 16, one-way RM ANOVA with post-hoc Tukey’s test, Base vs. Atro: p =
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0.0003***, Base vs. Atro + Carb: p = 0.0002***, Atro vs. Atro + Carb: p = 0.0070**) during
atropine and the following atropine and carbachol co-treatment. Atropine alone did not affect
AP half-width (Base = 1.09 ± 0.04 ms, Atro = 1.10 ± 0.04 ms). However, there was a small but
significant increase in AP half-width during the subsequent atropine and carbachol cotreatment (Figure 3L; Base = 1.09 ± 0.04 ms, Atro = 1.10 ± 0.04 ms, Atro + Carb = 1.15 ± 0.04
ms; F1.5,22 = 17.24, p = 0.0001***, n = 16, one-way RM ANOVA with post-hoc Tukey’s test, Base
vs. Atro: p = 0.2012, Base vs. Atro + Carb: p = 0.0012**, Atro vs. Atro + Carb: p = 0.0008***).

Though statistically significant, the changes in AP shape parameters in cells where carbachol
was applied first were much smaller compared to those cells where atropine was applied first
(compare Figure 3B, 3C, and 3D vs. Figure 3J, 3K, and 3L): carbachol treatment was
accompanied by 8.0% increase in threshold, 14.5% reduction in amplitude, and 13.3%
increase in half-width, while atropine was accompanied by 1.5%, 3.5%, and 0.9%, respectively.
When carbachol was added after atropine pretreatment, the changes in AP shape were also
smaller compared to those induced by carbachol alone, with 3.2% increase in threshold, 7.8%
reduction in amplitude, and 5.5% increase in half-width. Since the two sets of cells had the
same timeline of agonist and antagonist treatments but in reverse order, these results suggest
that carbachol-induced excitation was accompanied by significant changes in AP shape. In
contrast, atropine had minimal to no effects on AP shape and was able to block most of the
carbachol-induced effects. The small but persistent effects observed in Figure 3J, 3K and 3L
most likely correspond to the drift in the cellular condition and ion channel run-down during
the long recordings in the whole-cell mode.

Activation of muscarinic receptors does not alter action potential kinetics
Next, we analyzed the effects of mAChR activation on AP kinetics. The carbachol-induced
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changes in AP shape could involve at least two processes: inactivation of voltage-gated sodium
channels due to Vm depolarization and GPCR-mediated modifications of ion channel functions
via intracellular signaling (e.g., release of second messengers and protein phosphorylation).
Theoretically, sodium channel inactivation should be recovered by injection of hyperpolarizing
current, whereas signaling modifications of ion channels would be less dependent on the
baseline voltage reset, especially for proteins not modulated by voltage such as in the case of
the SK channel. To determine the contribution from these two processes, we used the
clamping circuit to restitute the original Vm during bath perfusion of carbachol and the
following atropine treatment of the set of cells shown in Figure 3B, C, D.

When the Vm was restituted to the baseline level, the average AP waveform during carbachol
application almost completely aligned with that prior to the agonist treatment (Figure 3A,
center panel). The carbachol-induced increases in AP threshold (Figure 3E; Carb = −35.43 ±
0.84 mV;) and AP half-width (Figure 3G; Carb = 1.26 ± 0.09 ms) were completely reversed by
restituting the baseline potential. The AP threshold value also did not differ from the baseline
during atropine treatment when Vm changes were compensated (Figure 3E; Atro = −35.88 ±
0.80 mV; F1.4,20 = 4.162, p = 0.0420*, n = 15, one-way RM ANOVA with post-hoc Tukey’s test,
which reveals no significant differences between treatments), although there was a slight
decrease in AP half-width with atropine compared to the baseline (Figure 3G; Atro = 1.24 ±
0.08 ms; F1.7,24 = 4.099, p = 0.0339*, n = 15, one-way RM ANOVA with post-hoc Tukey’s test,
Base vs. Carb: p = 0.4671, Base vs. Atro: p = 0.0482*, Carb vs. Atro: p = 0.1611). The only AP
shape parameter not completely reversed by Vm restitution was AP amplitude, which still
showed a slight reduction during carbachol treatment but not atropine treatment (Figure 3F;
Carb = 59.55 ± 1.31 mV, Atro = 60.58 ± 1.39 mV; F1.7,23 = 7.163, p = 0.0055**, n = 15, one-way
RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p = 0.0091**, Base vs. Atro: p = 0.2516,
Carb vs. Atro: p = 0.0577). This reduction in the AP amplitude was however much smaller
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(3.3% decrease) compared to that when Vm changes were uncompensated (14.5% decrease).

The kinetics of afterhyperpolarization (AHP) were also analyzed. In DA neurons, AHP kinetics
are regulated by SK and HCN channels and can influence firing patterns. Consistent with
previous reports (Richards et al., 1997), DA neurons exhibit prominent AHP with an average
peak amplitude of −25.54 ± 0.83 mV and an average duration of 16.56 ± 1.23 ms. During
carbachol application, the AHP amplitude and duration were apparently reduced (Figure 3A,
left panel). However, when the Vm changes were offset via current injection, both AHP
amplitude (Figure 3H; Carb = −25.61 ± 0.87 mV) and duration (Figure 3I; Carb = 16.12 ± 0.99
ms;) were restored to the baseline values. The kinetics of AHP only exhibited significant
changes during atropine application, when there was a small but significant reduction in AHP
amplitude (Figure 3H; Atro = −24.14 ± 0.82 mV; F1.9,27 = 23.27, p < 0.0001****, n = 15, oneway RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p = 0.9438, Base vs. Atro: p =
0.0002***, Carb vs. Atro: p = 0.0001***) and a large increase in the variability of AHP duration
that resulted in a longer mean duration (Figure 3I; Atro = 24.52 ± 3.11 ms; F1.0,15 = 8.694, p =
0.0096**, n = 15, one-way RM ANOVA with post-hoc Tukey’s test, Base vs. Carb: p = 0.6687,
Base vs. Atro: p = 0.0242*, Carb vs. Atro: p = 0.0271*). Taken together, these results showed
that the effects of carbachol on firing frequency and AP shape were secondary to Vm
depolarization. Although post-translational modifications and Gq/Ca2+-induced modulation of
ion channels may influence the carbachol effects on AP shape, the fact that these effects were
fully reversed by current injection strongly suggests that changes in a voltage-insensitive
conductance would be responsible for the carbachol-induced excitation.
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Figure 3. The muscarinic excitation was accompanied by alterations in action potential (AP)
shape, effects that were reversed when membrane potential changes were compensated.
(A) Average AP waveforms in 1-min intervals of VTA DA neuron spontaneous firing in baseline
(black) and after treatment with carbachol (red), membrane potential compensated by
current injection in the presence of carbachol (green), and a different cell in baseline and after
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application of atropine (blue). (B) Carbachol application raised AP threshold, (C) reduced AP
amplitude, and (D) increased AP half-width. Atropine reversed most of the carbachol-induced
effects on AP shape, which were also different from the baseline except AP half-width. (E, F,
G) Most effects of carbachol on AP shape were eliminated when the membrane potential was
restituted to baseline levels using the clamping circuit. Carbachol-induced positive shift in AP
threshold and broadening of AP half-width were fully reversed by current injection. The AP
amplitude reduction was partially reversed. (H, I) Carbachol had no effects on the amplitude
and duration of afterhyperpolarization (AHP) when membrane potential changes were
compensated. However, there were significant changes in the AHP amplitude and duration
during atropine treatment. (J, K, L) Atropine pretreatment had minimal effects on AP shape
and blocked most of the effects of carbachol, although there were progressive positive shift
in the AP threshold, reduction in the AP amplitude, and broadening of AP half-width. (* p <
0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001)
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Activation of muscarinic receptors does not alter most intrinsic membrane
properties
Previous work suggested that inhibition of voltage-gated potassium channels or calciumactivated potassium channels may underlie muscarinic excitation of DA neurons (Lacey et al.,
1990; Kitai et al., 1999). Furthermore, Gq signaling has been shown to activate HCN channels
in DA neurons (Goertz et al., 2015). To determine whether these ion channel mechanisms are
involved in carbachol-induced excitation, we performed current step experiments to assess
changes in intrinsic membrane properties (Figure 4A, B). First, we examined whether mAChR
activation alters the sag ratio, a conventional method for measuring HCN channel activity by
injection of a hyperpolarizing current step. Bath perfusion of carbachol and atropine had no
effect on the sag ratio evoked by the −200 pA step (Figure 4C; Base = 0.495 ± 0.025, Carb =
0.523 ± 0.028, Atro = 0.533 ± 0.030; F1.4,11 = 2.981, p = 0.1037, n = 9, one-way RM ANOVA).

Spike frequency adaptation ratio (FAR) and frequency-current (f-I) relationship were also
examined using the current step protocol. Those properties are affected by changes in
potassium conductances, including currents through SK channels and voltage-gated K+
channels, and correlate with spontaneous firing frequency and firing pattern in DA neurons
(Vandecasteele et al., 2011; Kimm et al., 2015). Carbachol and the subsequent atropine
treatment did not affect the FAR (Figure 4D; Base = 0.717 ± 0.051, Carb = 0.652 ± 0.052, Atro
= 0.636 ± 0.084; F1.2,8.2 = 1.401, p = 0.2779, n = 8, one-way RM ANOVA) or the average
stimulated firing frequency during the +200 pA step, which represents the highest point on a
f-I relationship plot (Figure 4E; Base = 7.76 ± 0.85 Hz, Carb = 8.29 ± 0.95 Hz, Atro = 8.11 ± 0.76
Hz; F1.3,11 = 1.010, p = 0.3629, n = 9, one-way RM ANOVA). Hence, the current step experiments
suggest that the participation of HCN and potassium channels in carbachol-induced excitation
is unlikely.

73

Figure 4. Activation of muscarinic receptors had no effects on sag ratio, frequency
adaptation ratio (FAR), and frequency-current (f-I) relationship. (A) The current step protocol
(600-ms, from −200 pA to +200 pA, 25 pA each step). (B) Representative voltage response of
a VTA DA neuron evoked by the current step protocol. (C) Carbachol had no effects on sag
ratio evoked by the −200 pA step. (D) Carbachol had no effects on spike frequency adaptation
ratio. (E) Carbachol had no effects on the stimulated firing frequency during the +200 pA step.
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Muscarinic stimulation does not affect inhibitory synaptic inputs in VTA DA
neurons
VTA DA neurons are tonically inhibited by GABAergic afferents (Westerink et al., 1996; Theile
et al., 2011), a major source being the local GABAergic interneurons (Polter et al., 2018).
Interestingly, previous work reported that VTA GABAergic neurons express the M3 mAChR and
are excited by muscarinic stimulation (Michel et al., 2004; Michel et al., 2005). Conversely,
there was a report that optogenetic stimulation of cholinergic terminals in the VTA inhibits
GABAergic neuron activity (Coimbra et al., 2021). Since the results here show that activation
of mAChRs had minimal effects on the intrinsic membrane properties or AP kinetics in DA
neurons, we speculated that carbachol may modulate DA neuron excitability via stimulating
the mAChRs on GABAergic neurons and altering inhibitory synaptic inputs to the DA neurons.
To test this possibility, a whole-cell voltage-clamp experiment was performed to record
spontaneous inhibitory post-synaptic currents (sIPSCs) in VTA DA neurons during bath
perfusion of muscarinic agents (Figure 5A). A Cs-based low-chloride intracellular solution with
the strong Ca2+ chelator BAPTA and the membrane-impermeant voltage-gated Na+ channel
blocker QX-314 was used to block most ion channels in the DA neurons (see methods). No
synaptic blockers were added to the bath solution to minimize disruption of tonic synaptic
activity. In order to minimize excitatory post-synaptic currents, sIPSCs were recorded by
clamping the cells at +15 mV, the reversal potential of ionotropic glutamate receptor currents.
Surprisingly, carbachol and the subsequent atropine treatment affected neither the average
frequency (Figure 5B; Base = 10.85 ± 1.73 Hz, Carb = 12.12 ± 2.05 Hz, Atro = 12.96 ± 2.32 Hz;
F1.4,21 = 4.358, p = 0.0369*, n = 16, one-way RM ANOVA with post-hoc Tukey’s test, which
reveals no significant differences, Base vs. Carb: p = 0.1886, Base vs. Atro: p = 0.0829, Carb vs.
Atro: p = 0.2528) nor the average amplitude of sIPSC events (Figure 5C; Base = 27.01 ± 1.28
pA, Carb = 27.89 ± 1.43 pA, Atro = 26.27 ± 1.40 pA; F1.7,26 = 5.072, p = 0.0171*, n = 16, one-
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way RM ANOVA with post-hoc Tukey’s test, which reveals a difference only between Carb and
Atro, Base vs. Carb: p = 0.2604, Base vs. Atro: p = 0.4217, Carb vs. Atro: p = 0.0029**). These
results showed that mAChR stimulation does not affect the fast inhibitory synaptic inputs to
DA neurons, consistent with a direct effect of carbachol on the DA neurons.
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Figure 5. Muscarinic receptor stimulation had no effects on spontaneous inhibitory
postsynaptic currents (sIPSCs) in VTA DA neurons. (A) Representative trace of sIPSCs in a VTA
DA neuron in baseline and after carbachol and atropine application. sIPSCs were recorded as
outward currents by holding the membrane potential at +15 mV. (B) Carbachol did not affect
the average frequency and (C) amplitude of sIPSCs in 3-minute intervals. (** p < 0.01)
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Muscarinic receptors depolarize VTA DA neurons via a TTX-insensitive
cationic conductance
Our results suggest that membrane potential depolarization accounts for most of the mAChRinduced effects at firing frequency and AP shape in VTA DA neurons. Therefore, we sought to
quantify the Vm depolarization and changes in input resistance (Ri) in the absence of
spontaneous firing activity. TTX (500 nM) was perfused in bath to silence spiking and revealed
low-amplitude calcium-dependent oscillations around a mean resting Vm of −44.43 ± 0.52 mV
(n = 65). Under this condition, bath perfusion of carbachol caused an average depolarization
of 2.68 ± 0.38 mV from the baseline potential −45.22 ± 0.80 mV to −42.53 ± 0.65 mV. This
depolarization was fully revered by atropine to −44.98 ± 0.70 mV (Figure 6A, C; Fr = 42.25, p
< 0.0001****, n = 32, Friedman test with post-hoc Dunn’s test: Base vs. Carb: p < 0.0001, Base
vs. Atro: p > 0.9999, Carb vs. Atro: p < 0.0001****). In agreement with the observations from
the whole-cell current-clamp experiments depicted in Figure 2 & 3, the carbachol-induced
depolarization was persistent and did not appear to desensitize. In a separate set of cells pretreated with atropine, atropine alone had no effects on Vm. This atropine pretreatment
blocked most of the carbachol-induced depolarization. (Figure 6B, E; Base = −43.66 ± 0.66 mV,
Atro = −44.08 ± 0.75 mV, Atro + Carb = −43.53 ± 0.67 mV; F1.8,59 = 3.359, p = 0.0453*, n = 33,
one-way RM ANOVA with post-hoc Tukey’s test, which reveals a difference only between Atro
and Atro + Carb, Base vs. Atro: p = 0.0927, Base vs. Atro + Carb: p = 0.8535, Atro vs. Atro +
Carb: p = 0.0453*). All of the cells tested appeared to be DAergic neurons expressing the
inhibitory D2 autoreceptor, since they showed strong hyperpolarization (~−20 mV) when
exposed to DA (60 M).

A small hyperpolarizing current step was injected every 22 s to assess the input resistance
throughout the experiment. Accompanying the Vm depolarization, carbachol induced a
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significant decrease in Ri by 106.5 ± 20.31 MΩ, which showed partial reversal by atropine
(Figure 6D; Base = 320.2 ± 28.49 MΩ, Carb = 213.6 ± 15.78 MΩ, Atro = 250.8 ± 19.00 MΩ;
F1.3,20 = 23.32, p < 0.0001****, n = 16, one-way RM ANOVA with post-hoc Tukey’s test, Base
vs. Carb: p = 0.0003***, Base vs. Atro: p = 0.0011**, Carb vs. Atro: p = 0.0065**). In contrast,
atropine alone had no significant effects on Ri, although there was a small reduction of Ri
during the following co-treatment of atropine and carbachol (Figure 6F; Base = 278.6 ± 34.87
MΩ, Atro = 263.9 ± 32.08 MΩ, Atro + Carb = 238.0 ± 27.32 MΩ; Fr = 14.00, p = 0.0009***, n =
16, Friedman test with post-hoc Dunn’s test, Base vs. Atro: p > 0.9999, Base vs. Atro + Carb: p
= 0.0012**, Atro vs. Atro + Carb: p = 0.0140*). The decrease in Ri induced by carbachol
suggests opening of ion channels, which is inconsistent with excitation mediated by inhibition
of potassium conductances. In our experimental settings, the intracellular and extracellular
ionic concentrations correspond to a theoretical potassium reversal potential at −103.56 mV,
a chloride reversal potential at −73.16 mV, a sodium reversal potential at 80.23 mV, and a
calcium reversal potential at 124.30 mV. Since the DA neurons have a resting Vm around −44
mV, the opening of K+ or Cl- channels would result in hyperpolarization, whereas the opening
of Na+ or Ca2+ channels would result in depolarization. Therefore, the results here suggest that
activation of a TTX-insensitive cation current, rather than inhibition of potassium current or
activation of chloride current, produces the main ionic conductance underling muscarinic
excitation of VTA DA neurons.
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Figure 6. Activation of muscarinic receptors depolarized membrane potential and decreased
input resistance in the presence of tetrodotoxin (TTX). (A, B) Representative whole-cell
current-clamp recordings of VTA DA neurons with continuous bath application of the voltagegated sodium channel blocker TTX, treated with carbachol or atropine in the labeled
respective order. A small current step was injected every 22 seconds to assess the input
resistance. (C) Carbachol depolarized membrane potential and (D) decreased input resistance.
(E) Atropine pretreatment prevented the effects of carbachol on membrane potential and (F)
input resistance. (* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001)
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Muscarinic receptors activate TRPC-like currents in VTA DA neurons
To further determine the ionic composition of the carbachol-activated conductance in VTA DA
neurons, we tested the sensitivity of carbachol-induced current to non-selective blockers of
Na+, Ca2+, and K+ channels using the whole-cell voltage-clamp technique. When held at a
constant Vm of −60 mV, all the DA neurons recorded exhibited a negative holding current with
an average amplitude of −119.4 ± 8.1 pA (n = 42). TTX (500 nM) was perfused throughout all
recordings to inhibit synaptic activities. TTX alone had no effects on the holding current, which
only changed by 4.0 ± 1.2 pA (n = 11) after the toxin was added. Under this condition, bath
perfusion of carbachol induced an inward current of −46.96 ± 5.51 pA, which was completely
blocked by atropine (Figure 7A; n = 11). When a separate set of DA neurons was treated with
the K+ channel blocker tetraethylammonium (TEA, 20 mM), there was a visible change in the
holding current (by 32.9 ± 7.7 pA, n = 7). Since the blocker alone caused a difference in the
baseline current, DA neurons were pretreated with TEA before the co-treatment of TEA and
carbachol to assess the degree of blockage more accurately (changes in the holding current
induced by different blockers are summarized in Figure 7E). Co-treatment with TEA
completely eliminated the carbachol-induced inward current (compare Figure 7B vs. Figure
7A; ICarb in TEA = 0.44 ± 1.25 pA, n = 7). Pretreating DA neurons with Cs+ (10 mM), another
blocker of K+ channels, caused a drastic change in the holding current (by 60.6 ± 15.8 pA, n =
9). This inhibition of the inward holding current is likely due to blockage of HCN channels. Bath
perfusion of carbachol in the presence of Cs+ induced an inward current (Figure 7C; ICarb in Cs+
= −76.67 ± 13.64 pA, n = 9) that was not significantly different from the control current. Finally,
a set of cells was pretreated with Cd2+ (200 M), a blocker of voltage-gated Ca2+ channels,
which also produced a change in the holding current (by 23.5 ± 3.8 pA, n = 8). In the presence
of Cd2+, the carbachol-induced current (Figure 7D; ICarb in Cd2+ = −18.34 ± 6.62 pA, n = 8) was
significantly different from that in Cs+, but not different from that in TEA and the control
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condition, indicating a partial blockage. The average amplitudes of ICarb in different blockers
and the post-hoc comparisons are summarized in Figure 7F (H3 = 24.86, p < 0.0001****, nCarb
= 11, nTEA = 7, nCs+ = 9, nCd2+ = 8, Kruskal-Wallis test with post-hoc Dunn’s test, Carb vs. TEA +
Carb: p = 0.0009***, Carb vs. Cs+ + Carb: p > 0.9999, Carb vs. Cd2+ + Carb: p = 0.2624, TEA +
Carb vs. Cs+ + Carb: p < 0.0001****, TEA + Carb vs. Cd2+ + Carb: p = 0.5119, Cs+ + Carb vs. Cd2+
+ Carb: p = 0.0242*)
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Figure 7. Inhibition of carbachol-induced inward current by non-selective ion channel
blockers. (A) Representative whole-cell voltage-clamp recording showing carbachol
application induced a TTX-insensitive inward current that was blocked by atropine. (B)
Pretreatment with TEA (20 mM) completely blocked the carbachol current. (C) Pretreatment
with Cs+ (10 mM) had no effects on the carbachol current, which was not different from
control but larger than in TEA. (D) Pretreatment with Cd2+ (200 M) caused a partial blockage
of the carbachol current that was not different from control and in TEA but smaller than in Cs+.
(E) Summary graph showing changes in the amplitudes of holding current by the ion channel
blockers alone. (F) Summary graph showing the amplitudes of carbachol-induced current in
the presence of the ion channel blockers. The asterisks denote statistical differences from
control (Carb with no blockers), unless indicated by brackets (* p < 0.05; *** p < 0.001; ****
p < 0.0001).
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The induction of carbachol current correlated with an increase of noise in the current traces.
Whole-cell current is the summed activities of all single channels. The openings and closings
are rapid flickering and stochastic events that produce fluctuations in the macroscopic
currents (Alvarez et al., 2002). Therefore, the amplitude of noise is a fair estimation of channel
activities. To quantify the noise, current traces from 10-sec intervals were plotted as frequency
histograms and fitted to Gaussian distribution (Figure 8A). In the control condition, carbachol
produced a robust increase in the standard deviation (SD) of current fluctuations, which was
reversed by atropine to the baseline value (Figure 8B; Base = 3.25 ± 0.16 pA, TTX = 3.26 ± 0.14
pA, Carb = 7.19 ± 0.79 pA, Atro = 3.60 ± 0.17 pA; F1.0,10 = 30.94, p < 0.0002***, n = 11, oneway RM ANOVA with post-hoc Tukey’s test, Base vs. TTX: p = 0.9988, Base vs. Carb: p =
0.0010**, Base vs. Atro: p = 0.0009***, TTX vs. Carb: p = 0.0009***, TTX vs. Atro: p =
0.0008***, Carb vs. Atro: p = 0.0015**).

Along with complete inhibition of the carbachol-induced current, TEA eliminated the
carbachol-induced current noise (Figure 8C; Base = 3.65 ± 0.24 pA, TEA = 3.35 ± 0.22 pA, TEA
+ Carb = 3.19 ± 0.17 pA; Fr = 12.29, p = 0.0003***, n = 7, Friedman test with post-hoc Dunn’s
test, Base vs. TEA: p = 0.0975, Base vs. TEA + Carb: p = 0.0015**, TEA vs. TEA + Carb: p =
0.5443). In fact, there was a small but significant reduction in noise with continuous TEA
perfusion relative to baseline even after carbachol was added, suggesting slow inhibition of
ion channels. In contrast, the levels of noise induced by carbachol were unaffected by the
presence of Cs+ but was subsequently blocked by atropine (Figure 8D; Base = 3.23 ± 0.21 pA,
Cs+ = 3.21 ± 0.29 pA, Cs+ + Carb = 8.37 ± 1.66 pA, Cs+ + Atro = 3.55 ± 0.41 pA; Fr = 12.77, p =
0.0052**, n = 7, Friedman test with post-hoc Dunn’s test, Base vs. Cs+: p > 0.9999, Base vs. Cs+
+ Carb: p = 0.0225*, Base vs. Cs+ + Atro: p > 0.9999, Cs+ vs. Cs+ + Carb: p = 0.0114*, Cs+ vs. Cs+
+ Atro: p > 0.9999, Cs+ + Carb vs. Cs+ + Atro: p = 0.0427*). In the presence of Cd2+, carbachol
was still able to increase noise significantly, although the subsequent atropine-induced

84
inhibition did not reach statistical significance (Figure 8E; Base = 3.64 ± 0.24 pA, Cd2+ = 3.51 ±
0.30 pA, Cd2+ + Carb = 5.62 ± 0.38 pA, Cd2+ + Atro = 3.95 ± 0.24 pA; Fr = 17.55, p = 0.0005***,
n = 8, Friedman test with post-hoc Dunn’s test, Base vs. Cd2+: p > 0.9999, Base vs. Cd2+ + Carb:
p = 0.0060**, Base vs. Cd2+ + Atro: p > 0.9999, Cd2+ vs. Cd2+ + Carb: p < 0.0006***, Cd2+ vs.
Cd2+ + Atro: p = 0.4882, Cd2+ + Carb vs. Cd2+ + Atro: p = 0.1990), suggesting the carbacholinduced noise is smaller in Cd2+ compared to control. In our experimental conditions, none of
the ion channel blockers changed the baseline noise level after 5 min of treatment, even
though they produced changes in the holding current.

When the changes in carbachol-induced noise in the presence of different blockers were
compared against one another, the noise increase in TEA was significantly smaller than both
control and Cs+ conditions. Noise increase in Cs+ was not significantly different from control,
while in Cd2+ was not significantly different from any other treatment, suggesting no blockage
by Cs+ and partial blockage by Cd2+. The data and the post-hoc comparisons are summarized
in Figure 8F (Carb = 3.93 ± 0.69 pA, TEA + Carb = -0.47 ± 0.12 pA, Cs+ + Carb = 5.15 ± 1.57 pA,
Cd2+ + Carb = 1.99 ± 0.32 pA; H3 = 19.34, p = 0.0002***, nCarb = 11, nTEA = 7, nCs+ = 7, nCd2+ = 8,
Kruskal-Wallis test with post-hoc Dunn’s test, Carb vs. TEA + Carb: p = 0.0005***, Carb vs. Cs+
+ Carb: p > 0.9999, Carb vs. Cd2+ + Carb: p = 0.6909, TEA + Carb vs. Cs+ + Carb: p = 0.0011**,
TEA + Carb vs. Cd2+ + Carb: p = 0.1382, Cs+ + Carb vs. Cd2+ + Carb: p = 0.6836). In summary, the
degrees of inhibition of the current noise by the blockers are consistent with inhibition of the
current amplitude. The increase in current fluctuations with carbachol application suggests
increased channel activities. Since the macroscopic current (I) is the product of the singlechannel current (i), the number of channels (N), and the open probability of the channel (Po),
or I = iNPo (Alvarez et al., 2002), the effects of carbachol could be mediated by increased
probability of channels opening, plasma membrane insertion of channels, increase in the
unitary conductance of the channels, or a combination of these mechanisms.
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Figure 8. Inhibition of carbachol-induced noise in the whole-cell current by non-selective
ion channel blockers. (A) Representative whole-cell voltage-clamp trace showing the
carbachol-induced inward current was accompanied by an increase of noise in the recordings.
The amplitudes of noise were quantified by plotting the current fluctuations in 10-s intervals
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as frequency histograms and fitting the histograms to Gaussian distribution. (B) Carbachol
induced an increase in the standard deviation (SD) of current fluctuations that was blocked by
atropine. (C) Pretreatment with TEA (20 mM) completely inhibited the carbachol-induced
noise. (D) Pretreatment with Cs+ (10 mM) did not inhibit the carbachol-induced noise. (E)
Pretreatment with Cd2+ (200 M) also did not inhibit the carbachol-induced noise. (F)
Summary graph showing changes in the current noise (noise in the blockers alone subtracted
from noise in carbachol) in the presence of different blockers. The data are consistent with
complete blockage of the noise by TEA, no blockage by Cs +, and partial blockage by Cd2+. The
asterisks denote statistical differences from baseline (Base) or control (Carb with no blockers),
unless indicated by brackets (* p < 0.05; ** p < 0.01; *** p < 0.001).
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This pharmacological profile shows that HCN channels, which are expected to be blocked by
Cs+, and voltage-gated Ca2+ channels, which should be completely blocked by Cd2+ but
unaffected by TEA, are unlikely to underlie the carbachol-induced current, suggesting that
another, as yet unidentified channel is required. Interestingly, previous work showed that Cd2+
inhibited TRPC6 channels with an IC50 of ~210 M (Inoue et al., 2001), comparable to the
concentration used here. In addition, TEA was found to block TRPC and TRPV channels
(Larsson et al., 2005; Rivera-Acevedo et al., 2012), while Cs+ permeates TRP channels and does
not cause blockage (McKemy et al., 2002; Feng, 2017). Therefore, members of the TRP
channel family are potential candidates mediating the carbachol-induced current. To test this
possibility, a set of DA neurons were treated with carbachol to induce a robust inward current
and current noise, followed by the co-treatment of carbachol with BTP2 (5 M), a blocker of
TRPC channels (Figure 9A). The inhibition kinetics of BTP2 was slow and required 10 min. of
incubation to reach maximum effect, as previously observed (He et al., 2005). After ~10 min
of bath perfusion, BTP2 significantly reduced the amplitude of carbachol current from −116.2
± 29.88 to −32.33 ± 11.70 pA (Figure 9B; t6 = 3.02, p = 0.0117*, n = 7, paired t-test),
corresponding to 67.0 ± 8.6% inhibition. The carbachol activation caused a significant increase
in the standard deviation of current noise from 3.56 ± 0.19 to 14.78 ± 2.74 pA. Co-treatment
with BTP2 reduced the noise amplitude to 6.55 ± 1.24 pA, which was not significantly different
from either the baseline or carbachol alone, consistent with partial blockage (Figure 9C; Fr =
14.00, p < 0.0001****, n = 7, Friedman test with post-hoc Dunn’s test, Base vs. Carb: p =
0.0005***, Base vs. Carb + BTP2: p = 0.1841, Carb vs. Carb + BTP2: p = 0.1841). These results
showed that a major component of the carbachol-induced current and increase in channel
activities is sensitive to BTP2, a relatively selective blocker of the TRPC subfamily. Taken
together, evidence from the present study suggests that activation of a cationic conductance
involving TRPC channels is a main mechanism underlying muscarinic excitation of VTA DA
neurons.
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Figure 9. Inhibition of carbachol-induced whole-cell current and current noise by a TRPC
channel blocker. (A) Representative whole-cell voltage-clamp recording showing inhibition of
carbachol-induced inward current by BTP2 (5 M), a blocker of TRPC channels. (B) BTP2
inhibited a major component (67.0 ± 8.6%) of the carbachol-induced inward current. (C) BTP2
caused a partial reduction in the carbachol-induced noise in the macroscopic currents. (* p <
0.05; *** p < 0.001)
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DISCUSSION
Cholinergic afferents originated in the PPT and LDT provide a major source of excitatory drive
to midbrain DA neurons. Activation of mAChRs on VTA DA neurons increases excitability and
is heavily implicated in reward and addiction-related behaviors. Here, we provide the first
evidence that a cationic conductance consistent with TRPC channel activation participates in
muscarinic excitation of VTA DA neurons. Our data show that the main effect of mAChR
agonism in VTA DA neurons is a persistent membrane potential depolarization concomitant
with a decrease in input resistance, whereas the shape of action potentials is changed because
of the membrane depolarization. The mAChR-induced depolarization is correlated with
activation of an inward current that exhibits a pharmacological profile suggestive of TRPC
channels. In addition, our data support a direct effect of muscarinic inputs on the DA neurons
as inhibitory synaptic currents are not altered by muscarinic stimulation. The consequence of
this muscarinic depolarization is an increase of pacemaking frequency without changes in the
firing pattern. While the involvement of other ion channel mechanisms is not completely
excluded, the results here suggest that HCN channels, SK channels, voltage-gated K+ channels,
voltage-gated Ca2+ channels, and NALCN are unlikely to be mediators of this excitation. Thus,
we identified TRPC channels as a likely downstream effector of muscarinic signaling that
provide a non-selective cationic current to increase the excitability of VTA DA neurons.

DA neurons of the lateral VTA and physiological implications
DA neurons of the VTA comprise subpopulations with heterogenous biochemical properties,
electrophysiological characteristics, and projection targets. While there is no distinct
boundary between the SNc and VTA, the mesostriatal DA system is arranged in a dorsolateral-
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ventromedial topography (Wise, 2009; Burton et al., 2015). Located laterally relative to the
VTA, the SNc receive cholinergic inputs from the PPT and send DAergic projections to the
dorsal striatum, both of which are laterally located. VTA predominantly receive cholinergic
inputs from the more medially located LDT and project to the NAc (Baik, 2020). Within the
VTA, DA neurons of the medial VTA are more heterogenous in their firing properties and
project to the medial NAc and the prefrontal cortex, whereas DA neurons of the lateral VTA
selectively project to the lateral NAc and possess intermediate properties between the VTA
and SNc (Roeper, 2013; Baik, 2020). Here, the majority of DA neurons studied are located in
the lateral VTA, in close proximity to the SNc. These DA neurons exhibit “conventional” SN-like
electrophysiological characteristics including slow pacemaking, broad AP width, prominent
voltage sag, delayed evoked firing, and sensitivity to DA (Lammel et al., 2008; Roeper, 2013)
that were used as selection criteria. Those properties indicate expression of HCN channels, Atype K+ channels, and D2 autoreceptors. The M5 mAChR is the primary muscarinic receptor
subtype expressed on midbrain DA neurons (Vilaro et al., 1990; Weiner et al., 1990; Reever et
al., 1997; Garzon & Pickel, 2013). Previous studies have shown that there is a lateral-medial
gradient of M5 mAChR expression, which is more concentrated in the SNc and lateral VTA
compared to the medial VTA (Gould et al., 2019). In the cell bodies of midbrain DA neurons,
the M5 mAChR is highly co-expressed with the D2 receptor (Vilaro et al., 1990; Weiner et al.,
1990). This suggests that the expression of M5 mAChR is correlated with “conventional”
electrophysiological characteristics in midbrain DA neurons.

Indeed, when the

aforementioned selection criteria are applied, almost all VTA DA neurons recorded in this
study responded to carbachol with increased excitation, suggesting the expression of M5
mAChR. There is recent evidence that DA neurons of the lateral VTA are selectively activated
by cholinergic inputs from the LDT. Optogenetic activation of cholinergic terminals in the VTA
is sufficient to induce conditioned place preference as well as increased motivation for a fixed
reward (Coimbra et al., 2021). These lateral VTA DA neurons signal to D1-expressing MSNs in
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the NAc core and shell (Coimbra et al., 2021), which are highly implicated in reward and the
development of drug addictions (Volkow et al., 2017). This suggests that the DA neurons
recorded in this study are the same population targeted by pontine cholinergic afferents
involved in reward and motivation signaling.

The electrophysiological similarity between SNc and lateral VTA DA neurons suggests that
these two populations of DA neurons likely share the same cholinergic signaling mechanisms,
which would affect motor and reward behaviors. In fact, we are the first to characterize
mAChR-induced current in VTA DA neurons in the voltage-clamp configuration. In previous
reports, in vitro application of muscarinic agonists to SNc DA neurons induced an inward
current with amplitude and kinetics that were not distinct from the current observed in our
study (Foster et al., 2014; Martini et al., 2019). This muscarinic current was associated with
an apparent increase in current noise (not quantified by previous work) and correlated with a
modest increase in pacemaking frequency and a broadening of AP half-width, effects that are
also consistent with our data. The physiological consequence of muscarinic activation is
promotion of DA release and DA-driven behaviors mediated by both nigrostriatal and
mesolimbic circuitry (Lester et al., 2010b), although modulation of motor and reward
behaviors are dissociable when cholinergic terminals in the SNc and in the VTA are selectively
targeted (Xiao et al., 2016). In support of the signaling similarities between SNc and VTA DA
neurons, M5 mAChR KO mice showed reduced locomotor and reward responses induced by
cocaine and morphine (Basile et al., 2002; Fink-Jensen et al., 2003; Thomsen et al., 2005; Steidl
& Yeomans, 2009). However, the in vivo studies also suggested motor function and foodmaintained behaviors are less sensitive to disruption of M5 mAChR signaling compared to the
reinforcing effects of addictive drugs. Although their psychomotor responses to cocaine and
morphine were attenuated, M5 mAChR KO mice did not differ in their operant responding to
liquid food, sensorimotor outputs, and motor skills (Fink-Jensen et al., 2003; Thomsen et al.,
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2005). Systemic administration of ML375, a M5-selective negative allosteric modulator,
attenuated self-administration of addictive drugs at a lower dose than that would cause motor
impairments (Berizzi et al., 2018; Gunter et al., 2018). Thus, despite SNc and VTA DA neurons
display similar electrophysiological response to muscarinic stimulation, the in vivo studies
suggest that pharmacological modulation of the M5 mAChR may be more effective at treating
addiction disorders than movement disorders. On the flip side, adverse motor effects may be
dose-limiting and restrict the usefulness of M5 mAChR-targeting strategies for treating other
DA-related disorders such as addictions, major depression, ADHD, and schizophrenia. Future
studies should investigate whether there exist circuitry or signaling differences in muscarinic
regulation of the mesolimbic and nigrostriatal DA pathways.

Muscarinic activation of TRPC channels in VTA DA neurons
Activation of TRPC channels by Gq signaling is a widely documented process in excitable and
non-excitable cells. TRPC channels comprise a subfamily of 7 members in the larger TRP
superfamily and are divided into the TRPC1, TRPC2, TRPC4/5, and TRPC3/6/7 subgroups based
on sequence homology and physiological functions (Clapham et al., 2001; Chen et al., 2020).
Except TRPC2, all TRPC subtypes are expressed throughout the brain (Clapham et al., 2001;
Nilius & Owsianik, 2011) and conduct non-selective cationic currents that modulate cellular
excitability, synaptic plasticity, and other critical neuronal functions (Bollimuntha et al., 2011).
In neurons, TRPC channels have been shown to underlie the excitatory response mediated by
a variety of Gq-coupled GPCRs, including mAChRs (Yan et al., 2009; Tai et al., 2011; Zhang et
al., 2011; Ratte et al., 2018), mGluRs (Hartmann et al., 2008; Riccio et al., 2009; Riccio et al.,
2014; Gualdani & Gailly, 2020), histamine H1 receptors (Sato et al., 2020), 5-HT2 receptors
(Munsch et al., 2003), and neuropeptide receptors (Riccio et al., 2009; Bollimuntha et al., 2011;
Riccio et al., 2014). Although the precise mechanisms of activation are not entirely understood,
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all TRPC subtypes are activated by PLC and multiple components of the Gq-mediated Ca2+
signaling pathway (Clapham et al., 2001; Chen et al., 2020; Wang et al., 2020). In general,
these comprise of two intricately related but dissociable pathways: store-operated calcium
entry (SOCE) and receptor-operated calcium entry (ROCE). SOCE can occur without receptor
stimulation and is triggered by ER Ca2+ store depletion, which leads to assembly of the STIMOrai complex and activation of TRPC channels (Cheng et al., 2011; Ambudkar et al., 2017).
ROCE is dependent on GPCR activation and is mainly mediated by generation of DAG, which
is a direct agonist of TRPC channels (Albert & Large, 2003; Itsuki et al., 2014; Storch et al.,
2017). PLC-mediated PIP2 depletion (Otsuguro et al., 2008; Trebak et al., 2009; Itsuki et al.,
2014) and direct binding of IP3 receptors to TRPC channels (Kiselyov et al., 1998; Tang et al.,
2001; Zhang et al., 2001) also contribute to ROCE. Thus, activation of TRPC channels appears
to be a core feature of Gq signaling, especially in the excitatory synapse of the central nervous
system.

Here, we show that TRPC channels are a likely component of mAChR-induced current in VTA
DA neurons by using pharmacological manipulations (Table 1). Our results show that the
carbachol-induced current and the concurrent increase in current noise is insensitive to TTX
(500 nM) and Cs+ (10 mM) but sensitive to TEA (20 mM) and Cd2+ (200 M). TRP channels
conduct non-selective cationic currents and permeate Na+, K+, Cs+, and Ca2+ with very little
selectivity (Inoue et al., 2001; McKemy et al., 2002; Feng, 2017). In fact, TTX and Cs+ added to
extracellular solutions, and/or intracellular solutions in which Cs+ is the major cation, are
typically used to isolate TRP channel currents (Zhang et al., 2011). The insensitivity of mAChRinduced excitation to TTX and Cs+ is also in agreement with previous work recorded from SNc
and VTA DA neurons (Lacey et al., 1990; Foster et al., 2014). Though information about the
interactions between TRP channels and other non-selective ion channel blockers is limited, it
appears that TRP channels are sensitive to blockage by quaternary ammonium compounds.

94
TEA potently inhibited capsaicin-induced TRPV1 currents in Xenopus oocytes with an IC50 of
41 nM (Rivera-Acevedo et al., 2012). The inhibition mechanism likely involves TEA binding to
negatively charged residues in the selectivity filter and is voltage-dependent, being more
effective at hyperpolarized (Vm = −60 mV) than at depolarized potentials (Rivera-Acevedo et
al., 2012). In HEK cells, the endogenous TRPC currents activated by the orexin 1 receptor was
completely inhibited by 70 mM TEA (Larsson et al., 2005). Although an IC50 was not
determined in the previous study with TRPC, it is possible that TEA is a potent blocker of TRPC
channels and would inhibit TRPC currents at a lower concentration, similar to its action on the
TRPV1 channel. Finally, TRPC channels show sensitivity to inhibition by Cd2+. Cd2+ inhibited
carbachol-induced TRPC6 currents in HEK cells and 1-adrenoceptor-activated TRPC6
currents in cultured vascular myocytes with IC50 values of 253 and 213 M, respectively (Inoue
et al., 2001). Our results show approximately half reduction in the amplitude of the carbacholinduced current by 200 M Cd2+, consistent with the previously reported IC50 value for TRPC6.
Interestingly, TRPC5 expressed in HEK cells was only inhibited by Cd2+ (100 M) after being
treated with the reducing agent DTT, which breaks an extracellular disulfide bridge that
uniquely confers redox sensitivity to TRPC1/4/5 channels (Xu et al., 2008). In our experimental
setting, the extracellular solution is constantly being oxygenated and likely creates an oxidizing,
rather than reducing, environment. Therefore, it is possible that the carbachol-induced
current in DA neurons is mainly mediated by the TRPC3/6/7 rather than the TRPC1/4/5
subgroup. In summary, the pharmacological profiling of carbachol-induced currents in DA
neurons using charged ion channel blockers points to a TRP-like non-selective cationic
conductance.

Since ionic or small molecule blockers such as Cs+, TEA, and Cd2+ have poor selectivity and
inhibit wide ranges of ion channels, the key result that suggests the involvement of TRPC
channels is sensitivity of the carbachol current to BTP2 (also known as Pyr2 or YM-58483).
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Our data show that co-treatment with BTP2 (5 M) inhibited a major component of the
carbachol-induced current (67%) and current noise. BTP2 is a small molecule pyrazole
derivative that inhibits both SOCE and ROCE with relatively high selectivity. In lymphocyte cell
and HEK cell lines, BTP2 inhibited thapsigargin-induced SOCE-mediated Ca2+ entry with an IC50
of 0.1-0.3 M (Ishikawa et al., 2003; He et al., 2005). It has been reported that BTP2 is slowacting, requiring an incubation of at least 10 min to reach the maximum effect (Zitt et al., 1996;
He et al., 2005). In our experiments, BTP2 also exhibited slower inhibition kinetics compared
to the aforementioned non-selective ion channel blockers. The kinetics were somewhat
variable between cells, although no further blockage was observed after 10 min of bath
perfusion, which matches the time course reported by He et al. (2005). When SOCE was
activated by a more physiological agent, the muscarinic agonist carbachol in HEK cells, BTP2
did not alter the initial store-mediated Ca2+ release but inhibited the subsequent extracellular
Ca2+ entry at 1 M (He et al., 2005). This suggests that BTP2 does not significantly affect
components of the signal transduction pathway that leads to SOCE, such as the mAChR, G
protein, PLC, and IP3 receptors. Importantly, at 3 M, BTP2 greatly reduced the open
probability of TRPC3 channels in single-channel recordings across the voltage range of −80 to
80 mV and completely inhibited OAG-induced TRPC3 currents in whole-cell recordings (He et
al., 2005). BTP2 still inhibited TRPC3 when TRPC3-mediated depolarization was prevented by
replacement of extracellular Na+ with the impermeant NMDG (He et al., 2005). Because the
inhibitory action was not a secondary effect of membrane potential changes, BTP2 likely
antagonizes TRPC channels directly. The direct binding to BTP2 and related compounds to
TRPC channels is supported by photoaffinity labeling experiment showing pull-down of a Pyr
derivative with TRPC3 (Kiyonaka et al., 2009). Therefore, though the exact binding site of BTP2
on TRPC channels has not been identified, it is highly likely that BTP2 acts as a direct inhibitor
of TRPC.
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While BTP2 antagonizes SOCE and ROCE non-selectively, this compound appears to be
selective for the TRPC subfamily relative to other ion channels. When the selectivity of BTP2
was examined using the same carbachol-induced Ca2+ or Sr2+ entry protocol, BTP2 suppressed
TRPC5 and TRPC6 activity with similar potency to that of TRPC3, whereas TRPV6-mediated
Ca2+ entry was unaffected by 10 M BTP2 (He et al., 2005). Instead of inhibition, it has been
suggested that BTP2 may activate TRPM4 in lymphocytes (Takezawa et al., 2006). Furthermore,
the TRPC3-selective BTP2 analogue Pyr3 failed to inhibit carbachol- and OAG-induced TRPM2,
TRMP4, and TRPM7 currents (Kiyonaka et al., 2009). These results suggest that the inhibitory
action of BTP2 is mainly mediated by antagonizing TRPC-type TRP channels. The selectivity of
BTP2 versus other cellular targets was further demonstrated by the lack of activity against
non-TRP components of the Ca2+ signaling pathway. In the catecholaminergic PC12 cell line,
BTP2 inhibited depolarization-induced Ca2+ influx through voltage-gated Ca2+ channels with
an IC50 of 4.7 M, which is 30-fold less than that for SOCE (Ishikawa et al., 2003). Even at 10
M, BTP2 did not significantly inhibit K+ channels endogenously expressed in Jurkat T cells,
such as Kv1.3, SK, and inward rectifiers (Zitt et al., 1996; Takezawa et al., 2006). Furthermore,
BTP2 was still effective when mitochondrial Ca2+ uptake and SERCA were inhibited and did not
affect Ca2+ extrusion rate, suggesting ER and mitochondrial Ca2+ signaling, as well as plasma
membrane Ca2+ pumps, were not altered by BTP2 (Zitt et al., 1996). Hence, while midbrain DA
neurons express a diverse repertoire of voltage-gated channels and functional TRPV1, TRPM2,
TRPM4, and TRPM7 channels (Mezey et al., 2000; Mrejeru et al., 2011; Sun et al., 2018; Sun
et al., 2020), the available data suggest that the inhibitory effects of BTP2 on the carbacholinduced current is likely mediated by combined blockage of TRPC channels and the STIM-Orai
complex, but not blockage of other TRP subfamilies, voltage-gated Ca2+ channels, or K+
channels.
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TTX

TEA

Cs+

Cd2+

BTP2

−

+

−

+

+

KV

− [1, 2]

+ [3, 4]

KCa (SK and BK)

− [2, 6]

+ [7, 8]

Kir (e.g., GIRK)

− [10]

NaV

+ [11]

− [4]

CaV

− [12]

− [12]

− [13]

+ [14]

HCN

− [16, 17]

− [16, 17]

+ [16]

− [17]

NALCN

− [18, 19]

− [19]

− [18]

− [20]

+ [21]

− [20]

Carbachol

TRPC

− [5]
− [9]

− [5]

+ [10]

− [5]

+ [22]

− [15]

+ [23]

Table 1: Summary of the pharmacological profile of the carbachol-induced current in VTA
DA neurons compared to that of a list of candidate channels. TRPCs are the only candidate
channels that exhibit a similar pharmacological profile as the carbachol-induced current in the
present study. Plus sign with green background indicates sensitivity to the ion channel blocker
whereas minus sign with orange background indicates insensitivity. (Note: only selective
members for each channel family are represented in this table both for the purpose of
simplification and the limitation of available data.)

References:
[1] (Hansen et al., 2006), [2] (Kimm et al., 2015), [3] (Koyama & Appel, 2006), [4] (Khodakhah
et al., 1997), [5] (Takezawa et al., 2006), [6] (Fiorillo & Williams, 1998), [7] (Monaghan et al.,
2004), [8] (Su et al., 2010), [9] (Yuhas & Fuchs, 1999), [10] (Davila et al., 2003), [11] (Tucker et
al., 2012), [12] (Philippart et al., 2016), [13] (Evans et al., 2017), [14] (Lansman et al., 1986),
[15] (Ishikawa et al., 2003), [16] (Liu et al., 2003), [17] (Gambardella et al., 2012), [18]
(Philippart & Khaliq, 2018), [19] (Kschonsak et al., 2020), [20] (Zhang et al., 2011), [21]
(Larsson et al., 2005), [22] (Inoue et al., 2001), [23] (He et al., 2005).
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Midbrain DA neurons express multiple subtypes of TRPC. All TRPC subtypes except TRPC2 are
expressed in the substantia nigra (Tozzi et al., 2003; Chung et al., 2007; Zeng et al., 2016).
Immunohistochemical studies by the Fusco Lab showed intense staining of TRPC1, TRPC5, and
TRPC6 in SNc DA neurons: TRPC1 and TRPC6 are expressed in the somatodendritic
compartments (Martorana et al., 2006; Giampa et al., 2007), TRPC5 was found localized in the
neuronal nuclei and did not co-localize with TRPC1 or mGluR1 (De March et al., 2006), while
TRPC3 showed preferential localization in oligodendrocytes and appeared to be absent in
most DA neurons of the SN (Fusco et al., 2004). However, a recent study showed that virtually
all TH+ SNc DA neurons (92% of cells) express TRPC3, which provide a cationic leak current
that maintains the pacemaking activity (Um et al., 2021). Inhibition of TRPC3 current by the
selective blocker Pyr3 hyperpolarized membrane potential and stopped the pacemaking of
SNc DA neurons without altering the kinetics of AP shape (Um et al., 2021). This result
contradicts the findings of the previous immunohistochemical studies and demonstrates an
essential role of TRPC3 in the physiological of SNc DA neurons. Compared to the SN, studies
of the expression and functions of TRPC in the VTA are scarce. One study showed expression
of TRPC4 in the SN and a subset (~37%) of VTA DA neurons that are uniformly-distributed
throughout this brain region (Klipec et al., 2016). In TRPC4 KO rats, ~1/3 of VTA DA neurons
showed lower spontaneous firing rates; the proportion of affected cells matched that express
the TRPC4 subunit (Klipec et al., 2016). Those TRPC4 KO rats were less socially exploratory and
showed reduced cocaine self-administration, suggesting TRPC4 may modulate selective
subpopulations of VTA DA neurons and circuit-specific DA-driven behaviors (Klipec et al.,
2016). In the TRPC channel literature, there is abundant evidence that one cell type commonly
expresses multiple TRPC subtypes, which may form homomeric or heterometic channels.
When forming heteromeric channels, TRPC subunits appear to preferentially assemble with
members of the same subgroup (e.g. TRPC1/4/5 co-assemble and TRPC3/6/7 co-assemble)
(Goel et al., 2002; Hofmann et al., 2002), but inter-subgroup heteromeric channels have also
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been reported (Strubing et al., 2003; Poteser et al., 2006; Yuan et al., 2007; Storch et al., 2012).
In our results, the majority of DA neurons of the lateral VTA responded to carbachol with
increased excitation and the induction of a BTP2-sensitive inward current. This is a larger
proportion than those expressing the TRPC4 subunit. Since BTP2 is non-selective for all TRPC
subtypes, the current data suggest that mAChRs in VTA DA neurons activate multiple subtypes
of TRPC, which possibly exist as heteromeric channels. In recent years, several high-affinity
small molecule inhibitors selective for TRPC subgroups have been developed [See reviews
(Chen et al., 2020; Wang et al., 2020; Gao et al., 2021)]. Future studies should utilize these
blockers or dominant-negative TRPC subunits to determine the specific subtypes underlying
the muscarinic response in midbrain DA neurons. In addition, in the context of developing
TRPC-targeting therapeutics for DA-related disorders, it would be important to map the
expression patterns of specific TRPC subtypes in the VTA and whether they co-localize with
the M5 mAChR.

In SNc DA neurons, TRPC1 has been shown to mediate SOCE and SOCE-related signaling. In
this brain region, thapsigargin-induced store depletion elicited an inward current around −100
pA in amplitude that was absent in TRPC1 KO mice (Selvaraj et al., 2012; Sun et al., 2017).
However, instead of generating an excitatory response, TRPC1 activation actually decreased
the pacemaking frequency in SNc DA neurons via inhibition of L-type Ca2+ current (Sun et al.,
2017). This effect appeared to be mediated by physical interaction between Cav1.3 and the
TRPC1-STIM1 complex and a decrease in the maximal conductance of Cav1.3 channels (Sun
et al., 2017). The antagonistic relationship between SOCE and L-type Ca2+ channels, termed
“store-inhibited channels”, has been discovered in various excitable cell types including
cortical neurons and vascular smooth muscle cells (Moreno & Vaca, 2011). Nonetheless, while
these studies show that DA neurons are equipped with the SOCE machinery comprising of
STIM-Orai and TRPC channels, the coupling of this signaling complex to GPCRs has not been
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demonstrated. One proposed mechanism underlying muscarinic excitation of VTA DA neurons
is an increase in L-type Ca2+ current (Zhang et al., 2005; Liu & Chen, 2008), which appear to
contradict the effects of “store-inhibited channels”. Our results also show that mAChR
activation increased VTA DA neurons pacemaking frequency, an opposite effect of storeoperated TRPC1 activation reported in the previous study. Therefore, while TRPC1-mediated
SOCE likely occurs upon muscarinic stimulation of DA neurons, it may not be the major
activation mechanism of TRPC channels downstream of this GPCR. Moreover, even though
BTP2 inhibits TRPC and Orai channels non-selectively, the SOCE current conducted by Orai
channels is very small (Ambudkar et al., 2017) and the divalent ion entry (i.e., Ca2+) is
insensitive to TEA blockage (Schindl et al., 2009). Thus, pure Orai-mediated current is unlikely
to be a major component of the carbachol-activated conductance measured by patch-clamp
recordings. In future studies, calcium imaging will be a more appropriate technique to
investigate SOCE downstream of muscarinic signaling in DA neurons.

In SNc DA neurons, mGluR1-mediated activation of a TRP-like currents via ROCE-related
mechanism is well-documented. TRPC1 and TRPC6 have been shown to express in the
somatodendritic compartments of SNc DA neurons and co-localize with mGluR1 (Martorana
et al., 2006; Giampa et al., 2007), making them the potential TRPC subtypes involved in the
excitatory mGluR1 response. In acute brain slice preparation, the mGluR1 agonist DHPG
elicited a non-selective cation current that correlated with membrane potential
depolarization and an increase in spontaneous firing frequency (Tozzi et al., 2003; Cucchiaroni
et al., 2010). Pharmacological characterization showed that this mGluR1-induced current was
sensitive to Na+ substitution and extracellular application of non-selective TRP channel
blockers such as SKF96365, 2-APB, ruthenium red, and flufenamic acid. Further experiments
revealed that the mGluR1-induced current was not altered by treatments that disrupt the
intracellular Ca2+ pathways: store depletion by thapsigargin and CPA, intracellular inclusion of
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the strong Ca2+ chelator BAPTA, or intracellular application of reagents that affect the IP3
receptors and ryanodine receptors including ryanodine, dantrolene, ruthenium red, and 2APB, even when they reduced the concurrent Gq-mediated Ca2+ transients (Tozzi et al., 2003).
This result is significant because it shows that the mGluR1-mediated response is not
dependent on Ca2+ store release, suggesting ROCE via the generation of DAG and/or rapid
membrane insertion of channels [see: (Cheng et al., 2011; Tai et al., 2011)] are the most likely
mechanisms of activation. Since cholinergic and glutamatergic inputs work in conjunction to
modulate the firing activity of DA neurons, it is possible that the molecular components
downstream of mGluR and mAChR signaling are in close proximity in the dendritic
microdomains. It would be interesting to determine the relative contribution of ROCE and
SOCE in muscarinic activation of TRPC currents using the experimental manipulations
discussed above, and whether mGluRs and mAChRs signal to the same or separate pools of
TRPC channels.

Despite the likelihood that activation of TRPC channels underlie both mGluR1- and mAChRinduced excitation in midbrain DA neurons, there are apparent differences in the magnitude
and kinetics of mGluR1- and mAChR-induced inward currents. The mGluR1 agonist DHPG
elicited a larger inward current with a peak amplitude around −350 pA (Tozzi et al., 2003;
Martini et al., 2019). It was reported that the mGluR1-induced current and Ca2+ transients
quickly desensitized with bath application or repeated application of the agonist (Guatteo et
al., 1999; Tozzi et al., 2003). Even in the same cell, the DHPG-induced current consistently had
larger amplitude and faster kinetics compared to the muscarine-induced current, which was
slow and had an average amplitude around −90 pA (Martini et al., 2019). Bath application of
muscarine did not reduce the DHPH-induced current (Martini et al., 2019), suggesting crossdesensitization does not occur. Our results show that bath perfusion of an mAChR agonist
induced a slow inward current that peaked at around −50 pA and membrane potential
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depolarization that were non-desensitizing. Together, those results suggest that there are
signaling differences between mGluR- and mAChR-mediated responses, although the
mechanisms responsible for these differences are unknown. Compared to the large-amplitude,
rapidly-desensitizing response of mGluR1, the mAChR response in DA neurons resembles the
mAChR-evoked TRPC-mediated plateau potential in the cortex and the hippocampus. In
cortical and hippocampal excitatory neurons, carbachol induced a slow, sustained
depolarization that leads to persistent AP spiking (Yan et al., 2009; Tai et al., 2011; Zhang et
al., 2011; Ratte et al., 2018). This depolarizing response does not desensitize and can last up
to 1 hour if the cholinergic stimulation is sustained (Zhang et al., 2011). The persistent nature
of the plateau potential is maintained by positive feedback interactions between TRPC
channel-induced depolarization and Ca2+ entry through voltage-gated Ca2+ channels (Ratte et
al., 2018). It is possible that such positive feedback mechanism also exists in midbrain DA
neurons to exert powerful excitatory control on pacemaking activity upon muscarinic
stimulation. PKC has been found to mediate the rapid desensitization of TRPC4/5 after
activation of Gq-coupled GPCRs. In HEK cells expressing TRPC5, the desensitization of
carbachol-induced TRPC5 current depended on extracellular and intracellular Ca2+,
intracellular ATP, and PKC phosphorylation of T972 on the C-terminal domain of TRPC5 (Zhu
et al., 2005). The T972 residue binds to PDZ domain-containing scaffold proteins such as
NHERF, which is a critical regulator of the activation kinetics and DAG sensitivity of receptoractivated TRPC4/5 currents (Obukhov & Nowycky, 2004; Storch et al., 2017). In the light of
these results, mAChR signaling in midbrain DA neurons may not be coupled to the PKC
pathway, or alternatively, activates other TRPC subtypes than TRPC4/5.

NALCN is another non-selective cation channel that plays an important role in the physiology
of midbrain DA neurons. NALCN provides a persistent sodium current that drives pacemaking
in VTA DA neurons (Khaliq & Bean, 2010). Recently, NALCN is found to play a similar role in
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SNc neurons. Using selective pharmacological inhibitors and KO mice, it was shown that
NALCN and TRPC3 contribute equally to sustained low depolarization that maintain
pacemaking activity of SNc neurons (Um et al., 2021). Despite being a leak channel, NALCN is
regulated by GPCRs. In VTA DA neurons, the neuropeptides neurotensin and substance P
activate a slow NALCN-mediated cation current (Lu et al., 2009). In pancreatic cells and HEK
cells, this leak channel is activated by the M3 mAChR (Lu & Feng, 2012). However, it should
be noted that although neurotensin receptor and M3 mAChR are preferentially coupled to the
Gq pathway, activation of NALCN is mediated through a G protein-independent but SFKdependent mechanism (Lu et al., 2009; Lu & Feng, 2012). This is in contrast with the proposed
G protein-dependent activation of TRPC channels. Being a TTX- and Cs+-insensitive leak cation
channel modulated by acetylcholine, NALCN it is another likely candidate underlying
muscarinic depolarization in VTA DA neurons. Although we demonstrated BTP2 sensitivity of
the carbachol-induced current in DA neurons, BTP2 has never been tested against NALCN. In
addition, BTP2 (5 M) did not fully block the carbachol-induced current. However, NALCN
heterologously expressed in HEK cells was not blocked by TEA (10 mM) (Chua et al., 2020;
Kschonsak et al., 2020) whereas the carbachol current was completely eliminated by 20 mM
TEA (Figure 7B, F), suggesting that NALCN is not a participant in this response. To determine
whether NALCN activity is regulated by mAChRs in DA neurons, future studies should test the
effects of L-703,606, a novel selective blocker of NALCN used by Um et al. (2021), and NALCN
KO on muscarinic actions in midbrain DA neurons.

Other ion channel mechanisms involved in cholinergic excitation of VTA DA
neurons
It is common for GPCRs to affect cell excitability via modulating the functions of multiple ion
channels. In addition to a “leak-like” cationic conductance, activation of voltage-gated Ca2+
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channels, inhibition of SK channels, and inhibition of voltage-gated K+ channels have also been
proposed to mediate the excitatory effects of muscarinic activation in midbrain DA neurons.
Here, one key finding that prompted us to examine activation of cationic channels was a
reduction in input resistance induced by carbachol. However, while a decrease in input
resistance and an increase in current noise indicate that the dominant ion carrier is cationic,
inhibition of K+ channels still could not be completely excluded. Upon muscarinic excitation,
Lacey et al. (1990) detected a decrease in membrane conductance between −50 and −65 mV
but an increase in conductance between −40 and −50 mV in midbrain DA neurons (Lacey et
al., 1990). Thus, it is possible that mAChR activation modulates multiple ion channels that are
activated at different membrane potentials. In addition, the TRPC channel blocker BTP2 did
not inhibit a minor component of the carbachol-induced current, suggesting activation of
other channels. This section will discuss the likelihood that other candidate channels are
involved in cholinergic excitation of VTA DA neurons.

Cholinergic neurotransmission is mediated by nAChRs and mAChRs. nAChRs are non-selective
cation channels that induce an inward current and excitation of DA neurons. Structurally,
carbachol is highly similar to acetylcholine and binds all cholinergic receptors non-selectively.
Therefore, activation of nAChRs may contribute to the excitatory effects of carbachol. The
study by the Chen Lab showed that carbachol depolarized membrane potential and induced
burst firing of VTA DA neurons in acute slice preparation via combined activation of nAChRs
and mAChRs (Zhang et al., 2005). However, while the excitatory role of nAChRs in DA neurons
is well-known, midbrain DA neurons predominantly express the 42 subtype of nAChRs that
are sensitive to agonist-induced desensitization. The excitatory nicotinic response
disappeared within a few minutes even upon treatment of sub-micromolar concentrations
(80-500 nM) of nicotine (Pidoplichko et al., 1997; Wooltorton et al., 2003; Pidoplichko et al.,
2004). In agreement, the Chen Lab showed that nicotinic activation by carbachol induced a
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transient depolarization and increase in firing that lasted ~1 min, while the muscarinic
response was slower (Zhang et al., 2005). In our study, we perfused the brain slices with
carbachol for at least 3-4 min before the measurements were taken, when most of the
nicotinic responses were expected to desensitize. We also showed that atropine could
reversed the carbachol-induced increase in firing frequency and carbachol-induced inward
current to baseline levels. Atropine is a prototypical mAChR antagonist that does not inhibit
42 nAChR currents activated by micromolar concentration of agonists (Zwart & Vijverberg,
1997). Nonetheless, there is a few carbachol-induced effects that were not completely
blocked by atropine. While atropine alone did not significantly affect Vm in the presence of
TTX, the subsequent atropine and carbachol co-treatment produced a very mild
depolarization. In spontaneously firing cells, carbachol induced a small decrease in on firing
regularity that was not reversed by atropine, which could be due to the burst-inducing effect
of nicotinic activation. These results suggest that while activation of nAChRs may account for
some of the carbachol-induced effects, it is not the major contributor of the slow
depolarization observed in this study.

SK channels are a master regulator of firing pattern in midbrain DA neurons. Coincidentally,
cholinergic inputs have been proposed to underlie the switch from tonic to burst firing.
Excitatory inputs from the PPT and LDT enable NMDA-induced bursting and cause an irregular
firing pattern (Lodge & Grace, 2006), effects that were consistent with SK channel inhibition.
Furthermore, SK channels are inhibited by the Gq-coupled 1-adrenoceptor in midbrain DA
neurons (Goertz et al., 2015). Thus, as elaborated by Kitai and colleagues, inhibition of SK
channels is a plausible mechanism underlying muscarinic excitation of DA neurons (Kitai et al.,
1999). Here, we provide evidence against the involvement of SK channels in the muscarinic
actions in VTA DA neurons. First, while DA neurons in acute slice preparation exhibit regular
pacemaking activity and do not burst, selective blockage of SK channels by apamin
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significantly decreased firing regularity, increasing the mean CoV of ISI from 0.05 to 0.30
(Deignan et al., 2012). In our experiments, the pacemaking of DA neurons remained highly
regular in all treatments. While there was a small increase of CoV of ISI from 0.056 to 0.092
during carbachol treatment in the whole-cell recordings, the difference is not present in the
cell-attached configuration and is much smaller compared to the effects of apamin. Second,
SK channels mediate the most hyperpolarizing phase of AHP (Shepard & Bunney, 1991; Ping
& Shepard, 1996). Modifications of SK channel function would affect the kinetics of AHP, an
effect that we did not observe. Finally, by regulating AHP kinetics, SK channel activities
influence spike frequency adaptation and f-I relationship (Shepard & Bunney, 1991;
Vandecasteele et al., 2011). In our current step protocol, carbachol did not affect the
frequency adaptation ratio and stimulated firing frequency. Instead of inhibiting SK channels,
it has been shown that mAChRs on DA neurons activate SK channels via stimulation of the Gq
pathway and release of intracellular Ca2+ (Fiorillo & Williams, 2000). The hyperpolarizing
response caused by SK channel activation is transient and, with prolonged receptor
stimulation, is replaced by a depolarization mediated by an unidentified conductance (Fiorillo
& Williams, 2000). In our bath perfusion protocol, we only observed depolarizing response
with carbachol. The lack of changes in firing regularity and spike frequency adaptation also
suggests that SK channel activity is not significantly affected after sustained muscarinic
stimulation. Together, our results do not place SK channel inhibition as a major mechanism of
the slow depolarization and increased firing rate resulting from muscarinic agonism in VTA DA
neurons.

The possibility that other potassium conductances are modulated by muscarinic inputs was
also examined. Midbrain DA neurons express a rich repertoire of potassium channels including
voltage-gated K+ channels, calcium-activated K+ channels, and GIRK channels. The voltagegated Kv7 channels are inhibited by the depletion of PIP2 mediated by Gq signaling and
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constitute the “M-current”, which depolarizes membrane potential and increases firing
frequency (Delmas & Brown, 2005). In heterologous expression systems, the Gq-coupled M1,
M3, and M5 mAChRs inhibit Kv7 current with equal efficacy (Guo & Schofield, 2003), making
the Kv7 channel a likely candidate. Kv7 channels mediate the slow component of AHP while
having minimal effects on other parameters of AP shape (Stocker, 2004; Koyama & Appel,
2006; Mateos-Aparicio et al., 2014; Greene & Hoshi, 2017), though the effects of Kv7 blockage
in midbrain DA neurons were somewhat conflicting across studies (Hansen et al., 2006;
Koyama & Appel, 2006; Sotty et al., 2009; Drion et al., 2010). Here, we failed to detect changes
in AHP kinetics and f-I relationship, properties that are affected by inhibition of Kv7 channels
(Hansen et al., 2006; Koyama & Appel, 2006). These data are consistent with the report of
Lacey et al. (1990), who showed that the slow activating inward current elicited by a
hyperpolarization step – a conventional method for measuring Kv7 activity – was unaffected
by muscarine treatment (Lacey et al., 1990). Therefore, although midbrain DA neurons exhibit
robust Kv7 current, Kv7 channels are not modulated by mAChRs in this native system. The
unchanged f-I relationship suggests that other prominent voltage-gated potassium
conductances, such as Kv4, the “A-type current”, and Kv2, are also not modulated by
muscarinic signaling even though inhibition of A-type currents was suggested to be a
widespread effect of Gq-mediated endocannabinoid mobilization (Gantz & Bean, 2017). The
lack of changes in AHP kinetics does not support the involvement of BK channels, which is
potentially activated by the Gq-mediated Ca2+ release and regulates the repolarization and
hyperpolarization phases of APs in DA neurons (Kimm et al., 2015). Lastly, GIRK channels have
been shown to be inhibited by Gq signaling in DA neurons (Kramer & Williams, 2016), but
these inward rectifiers are sensitive to Cs+ and would be blocked in our voltage-clamp
experiments. Thus, in addition to a decrease in input resistance, our examination of various
firing and pharmacological properties provides ample evidence that potassium conductances
are not main contributors in the mAChR-mediated excitation of DA neurons in our
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experimental conditions.

The voltage-gated cation channels include the HCN, voltage-gated Ca2+, and voltage-gated Na+
channels, which are all important regulators of firing pattern in midbrain DA neurons. HCN
channels conduct non-selective cation currents and contribute to membrane potential
depolarization during the pacemaking activity of DA neurons (Gambardella et al., 2012). In
addition, HCN channels regulate the shape of AHP by reducing the amplitude and duration of
AHP upon hyperpolarization (Neuhoff et al., 2002; Okamoto et al., 2006; Wanat et al., 2008).
Along with inhibition of SK channels, activation of HCN channels was shown to underlie the
excitatory actions of 1-adrenoceptor, a Gq-coupled GPCR, in midbrain DA neurons (Goertz
et al., 2015). Here, our data show that muscarinic activation did not affect the HCN-mediated
sag ratio and the kinetics of AHP. HCN channels are sensitive to blockage by extracellular Cs +
(3-5 mM) (Liu et al., 2003; Khaliq & Bean, 2010), and their action would be completely
eliminated in our voltage-clamp experiments using 10 mM Cs+. Moreover, HCN channels are
insensitive to TEA and Cd2+ (Liu et al., 2003; Okamoto et al., 2006; Gambardella et al., 2012).
This is drastically different from the pharmacological profile of the carbachol-induced current,
which is TEA- and Cd2+-sensitive but Cs+-insensitive. Therefore, our results provide strong
evidence that HCN activity is not altered by activation of mAChRs in DA neurons.

Work by Chen and colleagues have implicated activation of L-type Ca2+ channels in the
depolarizing and burst-inducing effects of muscarinic activation in VTA DA neurons (Zhang et
al., 2005; Liu & Chen, 2008). In their acute brain slice preparation, VTA DA neurons in the
presence of TTX exhibit very little to no membrane potential oscillations at baseline. Bath
application of carbachol induced robust Ca2+-mediated oscillations, which correlated with
induction of burst firing in 20% of cells. In contrast to their results, carbachol-induced burst
firing is a rare occasion in our preparation. Out of the 38 spontaneously firing VTA DA neurons
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recorded using cell-attached and whole-cell techniques, only 2 cells (5.3%) converted to burstlike firing pattern upon carbachol treatment. One cell was bursting with carbachol alone, while
the other cell only exhibited the unusual firing pattern with combined carbachol and
hyperpolarizing current injection. Due to the low number of samples, these cells were not
included in the data set and we did not pursue further. We speculate that the differences in
the techniques could account for our respective observations. While the previous studies used
perforated patch-clamp, we did not observe burst firing in the cell-attached experiments; both
techniques would preserve the intracellular content intact and make this a less likely factor.
The other major difference is the thickness of the brain slices prepared. Their 400-μm slices
were twice as thick as ours and could preserve more dendritic processes where the Ca2+
channels are located. Interestingly, while the Chen Lab demonstrated that the burst-inducing
effect of carbachol could be prevented by L-type Ca2+ channel blockers, there was a
component of carbachol-induced depolarization that was slow and insensitive to Cd2+ (100
M) and nifedipine. In our voltage-clamp experiments, the carbachol-induced current shows
high sensitivity to TEA (20 mM) but only partial sensitivity to Cd2+ (200 M), a pharmacological
profile inconsistent with Ca2+ channel currents. This suggests that, at least when Vm was held
constantly at -60 mV, voltage-gated Ca2+ channels are not major contributors to the mAChRinduced current. Therefore, while we appear to have reached different conclusions at the first
glance, our data in fact complement the previous findings. Together, our results suggest that
the ionic conductances modulated by mAChRs in midbrain DA neurons are complex. Our data
point to TRPC channels as additional effectors downstream of mAChR signaling that mediate
a non-selective cationic current and slow depolarization.

As previously discussed, 1-adrenoceptor excites midbrain DA neurons via activation of HCN
channels and inhibition of SK channels (Goertz et al., 2015), effects that are not observed for
mAChRs in the present study. This indicates that while both 1-adrenoceptor and M5 mAChR
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are preferentially coupled to the Gq protein, they signal to different downstream pathways in
DA neurons. The previous work on adrenergic effects in DA neurons did not pursue further
the signal transduction pathways, but we could speculate that PKC may underly these
differences. In midbrain DA neurons, regulation of HCN channels by PKC is complex, perhaps
due to different PKC isoforms and sites of phosphorylation. Serotonin has been reported to
inhibit HCN currents in DA neurons via Gq-mediated PKC activation (Liu et al., 2003;
Gambardella et al., 2012), while CRF enhanced HCN currents via activation of the PLC/PKC
pathway (Wanat et al., 2008). Therefore, it is possible that 1-adrenoceptor is coupled to PKC
activation in midbrain DA neurons, whereas mAChR lacks this mechanism. The differences in
PKC signaling may also account for the lack of M5 mAChR-mediated modulation of SK channels,
which have been shown to be inhibited by M1-mediated PKC activation in hippocampal
neurons (Buchanan et al., 2010). In addition, due to the role of PKC in the desensitization of
some TRPC channels (Zhu et al., 2005), the lack of PKC signaling may contribute to the
persistent, non-desensitizing nature of mAChR-evoked currents in DA neurons. However,
muscarinic activation of L-type Ca2+ channels and the accompanying excitation in VTA DA
neurons is attenuated by the PKC inhibitors chelerythrine and GF 109203X (Liu & Chen, 2008).
This implies that the mAChRs are capable of activating the PKC pathway. It remains to be
tested whether the differences between adrenergic and muscarinic signaling in midbrain DA
neurons lie in the PKC isoforms or other molecular mechanisms.

Muscarinic modulation of inhibitory synaptic inputs in VTA DA neurons
VTA DA neurons are tonically inhibited by the local GABAergic interneurons (Westerink et al.,
1996; Theile et al., 2011; Polter et al., 2018), which comprise of ~one-third of the total VTA
neuronal population (Nair-Roberts et al., 2008). Inhibition of VTA GABAergic interneuron
activity, which causes disinhibition of DA neurons, is implicated in the addictive properties of
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opioids, benzodiazepines, and alcohol (Nestler, 2005; Tan et al., 2011). Tracing studies showed
that cholinergic afferents from the PPT and LDT form synapses on VTA GABA neurons (Maskos,
2008). Nicotinic activation of VTA GABA neurons is important for GABA-dependent burst firing
of VTA DA neurons and the reinforcing effects of nicotine (Tolu et al., 2013), but it is unknown
whether the same GABA neurons express mAChRs and if they are modulated by muscarinic
activation. In studies using primary midbrain neuron cultures, GABA neurons showed
immunoreactivity for M3 mAChR (Michel et al., 2004). Agonists of mAChRs depolarize the
membrane potential, induce Ca2+ transients, and increase the firing frequency of the GABA
neurons (Michel et al., 2004; Michel et al., 2005). This increased excitation leads to an increase
in the frequency of sIPSCs recorded from neighboring neurons which the GABAergic neurons
synapse on (Michel et al., 2004). The mAChR-induced Ca2+ transient and increase in sIPSCs
were reduced by antagonists selective for the M3 mAChR (Michel et al., 2004; Michel et al.,
2005). Although it could not be certain that these primary GABAergic neurons are VTA GABA
interneurons, these results raise the possibility that muscarinic stimulation would excite
GABAergic neurons and increase the inhibition of VTA DA neurons. On the other hand, a
recent study showed that in vivo optogenetic activation of LDT cholinergic terminals in the
VTA increased the activity of most putative DA neurons and decreased the activity of most
putative GABA neurons. This suggests that cholinergic inputs inhibit VTA GABAergic
interneurons, though this effect could be mediated by nAChRs in the circuitry rather than
mAChRs. Here, we show that activation of mAChR by carbachol had no effects on the
frequency or the amplitude of sIPSCs recorded in VTA DA neurons. This result is surprising
because it suggests that VTA GABAergic interneurons are neither excited nor inhibited by
muscarinic inputs, which was not predicted by previous findings. While we failed to detect a
significant difference between the sIPSC amplitudes at baseline and during carbachol
treatment, there was a very small but significant decrease in the sIPSC amplitude during
atropine treatment compared to carbachol. If this difference is physiologically significant, it
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would suggest that VTA GABAergic neurons express excitatory subtypes of mAChRs, such as
M3 or M5. In the VTA, immunohistochemical staining for M2 and M5 mAChRs has found both
M2 and M5 localized on dendrites that do not express the dopamine transporter (DAT),
suggesting non-DAergic neurons (Garzon & Pickel, 2006, 2013). In line with these results,
while the majority of M5-expressing cells in the midbrain are TH+, a minority (~10%) are THbut co-express VGAT, indicating GABAergic identity (Gould et al., 2019). It is possible that only
specific sub-populations of VTA GABA neurons are excited by muscarinic activation and fail to
reach statistical significance in our sampling. Another limitation of our study is that we relied
solely on anatomical location and cell morphology to identify VTA DA neurons in this
experiment. The intracellular solution used to record sIPSCs contains the Na+ channel blocker
QX-314, the HCN and K+ channel blocker Cs+, and the Ca2+ chelator BAPTA. Blockage of major
ion channels in DA neurons prevented firing, activation of voltage sag, and D2 autoreceptor
response; thus, identification of cell type by electrophysiology was not possible. In future
studies, cell identities could be better determined by using transgenic animals expressing
fluorescent proteins under the promoters of DAergic and GABAergic markers.

Conclusions
The present work suggests that mAChRs directly excite VTA DA neurons via activation of TRPC
channels. This finding is supported by electrophysiological data showing that activation of
mAChRs induces an increase in pacemaking frequency due to membrane potential
depolarization. This increase in excitation was accompanied by a decrease in input resistance,
alterations of AP shape that were secondary to membrane depolarization, and no changes in
the firing pattern, suggesting HCN and K+ conductances are not involved. At hyperpolarized
potentials, activation of mAChRs induced a cationic inward current sensitive to a TRPC channel
blocker. Thus, our data suggest that TRPC channels are likely downstream effectors of mAChRs
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that bridge the mesopontine cholinergic inputs and the increase in midbrain DA neuron
excitability (Figure 10). Additional studies are needed to determine the specific signal
transduction pathways and TRPC subtypes mediating this excitation. Furthermore, this
research identifies novel molecular candidates for the treatment of neurological and
psychiatric disorders characterized by aberrant DAergic neurotransmission.
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Figure 10. Proposed mechanism of M5 mAChR-mediated activation of TRPC channels in
midbrain DA neurons. We predict that the M5 muscarinic acetylcholine receptor (mAChR) on
midbrain dopamine (DA) neurons activates transient receptor potential canonical (TRPC)
channels via a receptor-operated mechanism. The binding of acetylcholine (Ach) to the M5
mAChR activates Gq and phospholipase C (PLC), leading to PLC-mediated hydrolysis of
phosphatidylinositol 4,5-bisphosphate (PIP2) and production of diacylglycerol (DAG) and
inositol 1,4,5-triphosphate (IP3). DAG acts as a direct activator of TRPC channels. PIP2
depletion and the IP3-activated IP3 receptor also contribute to receptor-operated TRPC
channel activation. TRPC channels open and conduct a non-selective cation current, which
depolarizes and excites DA neurons.
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The insect protein was expressed in E. coli culture, purified using affinity chromatography,
and detected with Western blotting. The goal was to artificially produce JHBP for future
studies on insect endocrinology and pest control.
HONORS & AWARDS
2021

Charles C. Clayton Award, School of Medicine, Virginia Commonwealth
University

2021

Robert W. Ramsey Departmental Award, Department of Physiology &
Biophysics, Virginia Commonwealth University

2014

Graduated with Honors Degree, Dean’s List (7 semesters), University of
Wisconsin-Madison

2013

Hilldale Undergraduate/Faculty Research Fellowships, University of
Wisconsin-Madison

PUBLICATIONS
1. Ruchala, I., Battisti, U.M., Nguyen, V.T., Chen, R.Y., Glennon, R.A., Eltit, J.M. (2021).
Functional characterization of N-octyl-4-methylamphetamine variants and related
bivalent compounds at the dopamine and serotonin transporters using Ca 2+ channels as
sensors. Toxicology and Applied Pharmacology, 419, 115513. DOI:
10.1016/j.taap.2021.115513.
2. Bagdas, D., Jackson, A., Carper, M., Chen, R.Y., Akinola, L.S., & Damaj, M.I. (2020).
Impact of menthol on nicotine intake and preference in mice: Concentration, sex, and
age differences. Neuropharmacology, 108274. DOI:10.1016/j.neuropharm.2020.108274.
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3. Wu, D.C., Chen, R.Y., Cheng, T.C., Chiang, Y.C., Shen, M.L., Hsu, L.L., Zhou, N. (2018).
Spreading depression promotes astrocytic calcium oscillations and enhances
gliotransmission to hippocampal neurons. Cerebral Cortex, 28(9), 3204-3216. DOI:
10.1093/cercor/bhx192.
4. Shen, M.L., Wang, C.H., Chen, R.Y., Zhou, N., Kao, S.T., Wu, D.C. (2016). Luteolin
inhibits GABAA receptors in HEK cells and brain slices. Scientific Reports, 6, 27695.
DOI: 10.1038/srep27695.
CONFERENCE PRESENTATIONS
Chen, R.Y., Eltit, J.M., McQuiston, A.R. Electrophysiological characterization of muscarinic
excitation of dopamine neurons in the ventral tegmental area. Society for Neuroscience,
Global Connectome Virtual Conference, 2021.
PROFESSIONAL AFFILIATIONS
Society for Neuroscience (SfN)
COMMUNITY OUTREACH
Science blogging: writing scientific commentaries on a wide range of neuroscience and
physiology topics and posting biweekly on social media for a popular audience.
Neuroscience outreach: leading hand-on activities and giving oral presentations to local
middle and high school students with the VCU Neuroscience Interest Group.
Entomology outreach: assisting at booths sponsored by entomology labs, handling live
insects, and educating the public at both UW-Madison and VCU.

